<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="generate">
            <roleset id="generate.01" name="" wordnet="1">
                <roles>
                    <role n="0" descr="agent, causer&#x09;&#x09;//gene, process//&#x0A;" />
                    <role n="1" descr="thing created&#x09;&#x09;&#x0A;" />
                </roles>
                <example src="PERMUTATE" no="0">
                    <text>21-23 nt of long mature RNAs is generated by biceps RNase III Dicer. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>21-23 nt of long mature RNAs will be generated by biceps RNase III Dicer. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and HeLa mature cell mRNA was generated by a 3863-base RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and PRnd generates main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and Stat5aEE-AA DNA-binding mutant was generated by mino EE mutant acids (437 and 438) for AA.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and Stat5aEE-AA DNA-binding mutant will be generated by mino EE mutant acids (437 and 438) for AA.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and TBC method generates overlapping sequential fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a RNA fragment based on 3863 that occurs in the 5-untranslated region generates mRNA of heLa cells.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a functional interaction surface was generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a higher DNA complex was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a higher order DNA-protein complex was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a higher order DNA-protein complex will be generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a higher-order protein&#x13;DNA complex will be generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and a hypersensitive to DNase I was generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and an alternative coupling of the primary transcription of the gene generates HLA.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and bidentate RNase III generates mature RNA 21-23 nt.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and fumat will be generated by fumat B.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and high-order DNA-protein complex will be generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and hypersensitive to DNase I was generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1).</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and in anaerobically reacted with the purified NR Fe-S cluster generates spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and long mature RNAs of 21-23 nt will be generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and main transcripts of 1.7 and 2.7 kb was generated by prnd.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and main transcripts of 1.7 and 2.7 kb will be generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and mature RNA 21-23 nt was generated by the bidentate RNase III Dicer.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and motor was generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and nNOS generates superoxide.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and nNOS generates suspected.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and overlapping sequential fragments will be generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and sequential overlapping fragments will be generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and sequential superposition fragments will be generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and smoker B generates motor.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and some unusual symmetrical transcriptions will be generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and specific fragments was generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinitrosil-cysteine complex will be generated by does not react anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and the N-terminal RA generates a functional interaction surface.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and the TBC method generates overlapping sequential fragments.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and this binding generates a higher order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and this junction generates a higher-order protein DNA complex.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and Bydented RNase III dyce generated long RNAs of 21-23 nt.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and NO reacts anaerobicly with the purified NRF Fe-S cluster generated spectral changes consistent with the formation of a dinitrosyl-cysteine complex.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) generated hypersensitive to DNase I.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and TBC method generated sequential overlapping fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and TBC method generated sequential superposition fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="43">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and a 3863-base RNA fragment that occurs in the 5-interpreted region generated HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="44">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and a 3863-base RNA fragment that occurs in the 5-untranslated region generated HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="45">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and a RNA fragment based on 3863 that occurs in the 5-untranslated region generated mRNA of heLa cells.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="46">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) generated a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="47">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) generated a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="48">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and intergenic slicing with Prnp generated some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="49">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and none reacts anaerobically with the purified FNR group Fe-S generated spectral changes consistent with the formation of a dinitrosil-iron-cystein complex.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="50">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and this binding generated high-order DNA protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="51">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and this binding generated high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="52">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and this union generated high-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="53">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and us generated monoclonal antibody vs. FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="54">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and HLA is generated by an alternative coupling of primary genetic transcription.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="55">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and HLA was generated by an alternative coupling of primary genetic transcription.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="56">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and HLA was generated by an alternative coupling of primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="57">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and HLA will be generated by an alternative coupling of primary genetic transcription.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="58">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and L723 to H3 generated the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="59">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and NONE reacts anaerobically with the purified FNR group FNR generated spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="60">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and None reacts anaerobically with the purified Fe-S group of NRF generated spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="61">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and Stat5aEE-AA DNA-binding mutant will be generated by EE amino acids (437 and 438) for AA.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="62">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and TBC method generated sequential superposition fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="63">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and The biceps RNase III Dicer generated the 21-23 nt of long mature RNAs.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="64">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and The biceps RNase III Dicer generates long RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="65">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and The biceps RNase III Dicer generates long mature RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="66">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a 3863-based RNA fragment that occurs in the 5-untranslated region generated matur HeLa cell mRNA.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="67">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) generates a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="68">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a higher DNA complex will be generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="69">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a higher DNA-protein complex was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="70">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a higher order DNA-protein complex will be generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="71">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a higher-order protein&#x13;DNA complex will be generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="72">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a higher-order protein-DNA complex will be generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="73">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a hypersensitive DNase I was generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="74">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a hypersensitive DNase I will be generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="75">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and an RNA fragment of 3863 bases occurring in the 5-interpreted region generates mRNA of mature HeLa cells.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="76">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and an alternative coupling of primary gene transcription generates HLA.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="77">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and an alternative coupling of primary transcription of the gene generated HLA.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="78">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and fumat B generated fumat.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="79">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and high-order DNA-protein complex will be generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="80">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and high-order protein-DNA complex is generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="81">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and hypersensitive to DNase I will be generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1).</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="82">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and intergenic slicing with Prnp generates some unusual chimeric transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="83">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and intergenic spike with Prnp generates some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="84">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and large transcriptions of 1.7 and 2.7 kb is generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="85">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and long RNAs of 21-23 nt is generated by Bydented RNase III dyce.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="86">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and main transcripts of 1.7 and 2.7 kb is generated by prnd.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="87">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and main transcripts of 1.7 and 2.7 kb was generated by prnd.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="88">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and mature RNA 21-23 nt will be generated by the bidentate RNase III Dicer.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="89">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and mature hela cell mRNA is generated by a 3863 bases RNA chain that occurs in the non-translated region 5.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="90">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and monoclonal antibody against FHL2 was generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="91">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and nodes generates monoclonal antibody against FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="92">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and nodes generates monoclonal antibody vs. FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="93">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and none reacts anaerobically with the purified F-S group of FNR generated spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="94">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and prnd generated main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="95">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and proteolysis of amyloid precursor proteins (APP) generates Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="96">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and sequential fragment overlapping was generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="97">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and sequential overlapping fragments will be generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="98">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and sequential superposition fragments will be generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="99">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and smoker B generated moker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="100">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and smoker was generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="101">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and some unusual chemical transcriptions was generated by intergenic spike with Prnp.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="102">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and some unusual symmetrical transcriptions will be generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="103">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex is generated by NONE reacts anaerobically with the purified FNR group FNR.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="104">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and spectral changes consistent with the formation of a dinitrosil-cysteine complex is generated by None reacts anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="105">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and spectral changes consistent with the formation of a dinitrosil-cysteine complex is generated by does not react anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="106">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex is generated by no anaerobic reactions with the purified FNR Fe-S group.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="107">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex will be generated by no anaerobic reactions with the purified FNR Fe-S group.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="108">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex will be generated by none reacts anaerobically with the purified F-S group of FNR.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="109">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and spectral changes consistent with the formation of a dinitrosyl-cysteine complex was generated by NO reacts anaerobicly with the purified NRF Fe-S cluster.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="110">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and superoxide will be generated by NNOS.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="111">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and superposed sequential defects was generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="112">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and suspected was generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="113">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and suspected will be generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="114">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and the 21-23 nt of long mature RNAs is generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="115">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and the N-terminal RA generates a functional interaction surface.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="116">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and the TBC method generates superposed sequential defects.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="117">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and the term N-AR generated a functional interaction surface.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="118">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and this binding generated a higher DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="119">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and this binding generated a higher order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="120">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and this binding generated high-order DNA protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="121">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and this binding generated high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="122">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and this junction generates a higher-order protein DNA complex.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="123">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and this union generated a higher-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="124">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and Stat5aEE-AA DNA-binding mutant has been generated by mino EE mutant acids (437 and 438) for AA.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="125">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and a high-order DNA-protein complex has been generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="126">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and a higher DNA complex has been generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="127">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and a higher order DNA-protein complex has been generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="128">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and a hypersensitive DNase I has been generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="129">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and high-order DNA-protein complex has been generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="130">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and mRNA of mature HeLa cells has been generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="131">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and main transcripts of 1.7 and 2.7 kb has been generated by PRnd.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="132">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and main transcripts of 1.7 and 2.7 kb has been generated by prnd.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="133">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and monoclonal antibody vs. FHL2 has been generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="134">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and sequential superposition fragments has been generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="135">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and smoker has been generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="136">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and some unusual chimeric transcriptions has been generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="137">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex has been generated by NONE reacts anaerobically with the purified FNR group FNR.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="138">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and spectral changes consistent with the formation of a dinitrosil-cysteine complex has been generated by None reacts anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="139">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and the correct three-dimensional interaction surface has been generated by L723 in H3.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="140">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and Stat5aEE-AA DNA-binding mutant is generated by mino EE mutant acids (437 and 438) for AA.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="141">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and a functional interaction surface is generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="142">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and a higher order DNA-protein complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="143">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and high-order DNA protein complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="144">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and overlapping sequential fragments is generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="145">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and overlapping sequential fragments is generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="146">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and sequential fragment overlapping is generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="147">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and sequential superposition fragments is generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="148">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and some unusual chemical transcriptions is generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="149">
                    <text>A0 generated the correct three-dimensional interaction surface within the recombinant synapses.</text>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="150">
                    <text>A1 is generated by mino mutant acids EE (437 and 438) to AA (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                </example>
                <example src="PERMUTATE" no="151">
                    <text>Abeta peptides (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by proteolysis of amyloid precursor proteins.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="152">
                    <text>Abeta peptides (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by proteolysis of amyloid precursor proteins (APP).</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="153">
                    <text>Abeta peptides (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by proteolysis of amyloid precursor proteins.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="154">
                    <text>Abeta peptides (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by proteolysis of amyloid precursor proteins.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="155">
                    <text>Abeta peptides are generated by proteolysis of amyloid precursor proteins.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="156">
                    <text>Abeta peptides can be generated by proteolysis of amyloid precursor proteins.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="157">
                    <text>Abeta peptides can be generated from A0 (proteolysis of amyloid precursor proteins (APP) by beta- and gamma-secretases.</text>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="158">
                    <text>Abeta peptides is generated by proteolysis of amyloid precursor proteins (APP) within the recombinant synapse.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="159">
                    <text>Abeta peptides is generated by proteolysis of amyloid precursor proteins (APP) within the recombinant synapses.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="160">
                    <text>Abeta peptides is generated by proteolysis of amyloid precursor proteins whose elimination removes the FHL2 link.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="161">
                    <text>Abeta peptides were generated by proteolysis of amyloid precursor proteins (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="162">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that 21-23 nt of long mature RNAs has been generated by biceps RNase III Dicer.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="163">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that NNOS generates superoxide.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="164">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that NONE reacts anaerobically with the purified FNR group FNR has generated spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="165">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that Stat5aEE-AA was generated by A0 (L723 in H3.</text>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="166">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that TBC method has generated sequential overlapping fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="167">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex has generated a hypersensitive DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="168">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a functional interaction surface has been generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="169">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a high-order protein DNA complex was generated by A0 (L723 in H3.</text>
                    <arg n="1">a high-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="170">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a hypersensitive to DNase I has been generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="171">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that abeta peptides was generated by A0 (L723 in H3.</text>
                    <arg n="1">abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="172">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that an alternative coupling of primary gene transcription generates HLA.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="173">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that an alternative coupling of primary gene transcription has generated HLA.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="174">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that fumatase B generates fumat.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="175">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that in anaerobically reacted with the purified NR Fe-S cluster generates spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="176">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that intergenic slicing with Prnp generates some unusual symmetrical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="177">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that intergenic spike with Prnp has generated some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="178">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that long mature RNAs of 21-23 nt has been generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="179">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that mino EE mutant acids (437 and 438) for AA has generated Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="180">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that mino mutant acids EE (437 and 438) to AA has generated the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="181">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that monoclonal antibody vs. FHL2 has been generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="182">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that monoclonal antibody vs. FHL2 has been generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="183">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that nNOS generates superoxide.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="184">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that nodes has generated monoclonal antibody against FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="185">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that none reacts anaerobically with the purified FNR group Fe-S has generated spectral changes consistent with the formation of a dinitrosil-iron-cystein complex.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="186">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that overlapping sequential fragments has been generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="187">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that peptides abeta is generated by A0 (L723 in H3.</text>
                    <arg n="1">peptides abeta</arg>
                </example>
                <example src="PERMUTATE" no="188">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that proteolysis of amyloid precursor proteins (APP) has generated Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="189">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that sequential fragment overlapping has been generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="190">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that sequential overlapping fragments has been generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="191">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that smoker B generates smoker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="192">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that smoker B has generated motor.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="193">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that specific fragments has been generated by degradation.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="194">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that spectral changes consistent with the formation of a dinitrosil-cysteine complex has been generated by None reacts anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="195">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that the 21-23 nt of long mature RNAs has been generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="196">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that the DNA-binding mutant (Stat5aEE-AA) of Stat5a has been generated by mino mutant acids EE (437 and 438) to AA.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="197">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that the TBC method generates overlapping sequential fragments.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="198">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that this binding generates a higher DNA complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="199">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that this binding generates high-order DNA protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="200">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that this binding has generated a high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="201">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that this union has generated high-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="202">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that us has generated monoclonal antibody against FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="203">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that EE amino acids (437 and 438) for AA generates Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="204">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that HLA has been generated by an alternative coupling of primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="205">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that NNOS generates superoxide.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="206">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that NONE reacts anaerobically with the purified FNR group FNR has generated spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="207">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that None reacts anaerobically with the purified Fe-S group of NRF has generated spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="208">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that Prnd has generated large transcriptions of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="209">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that Prnd has generated main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="210">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) generates hypersensitive to DNase I.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="211">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a 3863-base RNA fragment that occurs in the 5-untranslated region generates HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="212">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a RNA fragment based on 3863 that occurs in the 5-untranslated region generates mRNA of heLa cells.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="213">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a RNA fragment based on 3863 that occurs in the 5-untranslated region has generated mRNA of heLa cells.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="214">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex has generated a hypersensitive chromatin I remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="215">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a high-order protein DNA complex was generated by A0 (L723 in H3.</text>
                    <arg n="1">a high-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="216">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a higher DNA-protein complex has been generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="217">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that an alternative coupling of primary gene transcription has generated HLA.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="218">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that an alternative coupling of primary transcription of the gene has generated HLA.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="219">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that an alternative coupling of the primary transcription of the gene generates HLA.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="220">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that an alternative coupling of the primary transcription of the gene has generated HLA.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="221">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that bidentate RNase III has generated mature RNA 21-23 nt.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="222">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that fumat has been generated by fumat B.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="223">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that long RNAs of 21-23 nt has been generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="224">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that main transcripts of 1.7 and 2.7 kb has been generated by PRnd.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="225">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that main transcripts of 1.7 and 2.7 kb has been generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="226">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that moker has been generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="227">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that monoclonal antibody against FHL2 has been generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="228">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that motor has been generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="229">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that overlapping sequential fragments has been generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="230">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that proteolysis of amyloid precursor proteins (APP) has generated Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="231">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that some unusual chimeric transcriptions has been generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="232">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that spectral changes consistent with the formation of a dinitrosyl-cysteine complex has been generated by NO reacts anaerobicly with the purified NRF Fe-S cluster.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="233">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that suspected has been generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="234">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that the term N-AR has generated a surface of functional interaction.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="235">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that this binding generates a higher order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="236">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that this binding has generated a higher DNA complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="237">
                    <text>Bydented RNase III dyce can generate long RNAs of 21-23 nt (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="238">
                    <text>Bydented RNase III dyce generated long RNAs of 21-23 nt-G molecules of human leukocytes.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="239">
                    <text>Bydented RNase III dyce generates long RNAs of 21-23 nt (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="240">
                    <text>Bydented RNase III dyce generates long RNAs of 21-23 nt.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="241">
                    <text>CTB method can generate A1 (The DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">CTB method</arg>
                </example>
                <example src="PERMUTATE" no="242">
                    <text>EE amino acids (437 and 438) for AA has generated Stat5aEE-AA DNA-binding mutant for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="243">
                    <text>HLA (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by an alternative coupling of primary gene transcription.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="244">
                    <text>HLA (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by an alternative coupling of primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="245">
                    <text>HLA (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by an alternative coupling of the primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="246">
                    <text>HLA are generated by an alternative coupling of the primary transcription of the gene .</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="247">
                    <text>HLA can be generated by an alternative coupling of primary genetic transcription.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="248">
                    <text>HLA is generated by an alternative coupling of primary genetic transcription.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="249">
                    <text>HLA was generated by an alternative coupling of primary gene transcription within the recombinant synapse.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="250">
                    <text>HLA was generated by an alternative coupling of primary genetic transcription.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="251">
                    <text>HLA was generated by an alternative coupling of the primary transcription of the gene within the recombinant synapse.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="252">
                    <text>HLA were generated by an alternative coupling of primary genetic transcription (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="253">
                    <text>HLA will be generated by an alternative coupling of primary gene transcription.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="254">
                    <text>HLA will be generated by an alternative coupling of primary genetic transcription.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="255">
                    <text>HLA will be generated by an alternative coupling of primary genetic transcription. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="256">
                    <text>HLA will be generated by an alternative coupling of primary transcription of the gene. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="257">
                    <text>HeLa mature cell mRNA (carot, and permease from DcuB to motor, carot and aspartate) were generated by a 3863-base RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="258">
                    <text>HeLa mature cell mRNA are generated by a 3863-base RNA fragment that occurs in the 5-untranslated region .</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="259">
                    <text>HeLa mature cell mRNA is generated by a 3863-base RNA fragment that occurs in the 5-interpreted region within the recombinant synapses.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="260">
                    <text>HeLa mature cell mRNA is generated by a 3863-base RNA fragment that occurs in the 5-untranslated region within the recombinant synapse.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="261">
                    <text>HeLa mature cell mRNA were generated by a 3863-base RNA fragment that occurs in the 5-interpreted region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="262">
                    <text>HeLa mature cell mRNA were generated by a 3863-base RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="263">
                    <text>HeLa mature cell mRNA will be generated by a 3863-base RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="264">
                    <text>In addition, Bydented RNase III dyce generates long RNAs of 21-23 nt, as its elimination removes the FHL2 link.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="265">
                    <text>In addition, L723 in H3 generates the correct three-dimensional interaction surface, as its elimination removes the FHL2 link.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="266">
                    <text>In addition, PRnd, whose elimination removes the FHL2 link, generates main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="267">
                    <text>In addition, SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) generates hypersensitive to DNase I, as its elimination removes the FHL2 link.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="268">
                    <text>In addition, TBC method generates sequential overlapping fragments, as its elimination removes the FHL2 link.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="269">
                    <text>In addition, TBC method, whose elimination removes the FHL2 link, generates overlapping sequential fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="270">
                    <text>In addition, The biceps RNase III Dicer, whose elimination removes the FHL2 link, generates long mature RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="271">
                    <text>In addition, a 3863 bases RNA chain that occurs in the non-translated region 5, whose elimination removes the FHL2 link, generates mature hela cell mRNA.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="272">
                    <text>In addition, a 3863-base RNA chunk that occurs in the 5-untranslated region, whose elimination removes the FHL2 link, generates mature heLa cell mRNA.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="273">
                    <text>In addition, a 3863-based RNA fragment that occurs in the 5-untranslated region, whose elimination removes the FHL2 link, generates matur HeLa cell mRNA.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="274">
                    <text>In addition, a RNA fragment based on 3863 that occurs in the 5-untranslated region generates mRNA of heLa cells, as its elimination removes the FHL2 link.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="275">
                    <text>In addition, a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1), whose elimination removes the FHL2 link, generates a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="276">
                    <text>In addition, a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) generates a hypersensitive to DNase I, as its elimination removes the FHL2 link.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="277">
                    <text>In addition, a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1), whose elimination removes the FHL2 link, generates a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="278">
                    <text>In addition, an alternative coupling of primary genetic transcription generates HLA, as its elimination removes the FHL2 link.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="279">
                    <text>In addition, an alternative coupling of primary transcription of the gene, whose elimination removes the FHL2 link, generates HLA.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="280">
                    <text>In addition, bidentate RNase III generates mature RNA 21-23 nt, as its elimination removes the FHL2 link.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="281">
                    <text>In addition, does not react anaerobically with the purified Fe-S group of NRF, whose elimination removes the FHL2 link, generates spectral changes consistent with the formation of a dinitrosil-cysteine complex.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="282">
                    <text>In addition, in anaerobically reacted with the purified NR Fe-S cluster generates spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex, as its elimination removes the FHL2 link.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="283">
                    <text>In addition, intergenic slicing with Prnp, whose elimination removes the FHL2 link, generates some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="284">
                    <text>In addition, mino mutant acids EE (437 and 438) to AA generates the DNA-binding mutant (Stat5aEE-AA) of Stat5a, as its elimination removes the FHL2 link.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="285">
                    <text>In addition, no anaerobic reactions with the purified FNR Fe-S group generates spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex, as its elimination removes the FHL2 link.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="286">
                    <text>In addition, prnd, whose elimination removes the FHL2 link, generates main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="287">
                    <text>In addition, smoker B generates motor, as its elimination removes the FHL2 link.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="288">
                    <text>In addition, smoker B, whose elimination removes the FHL2 link, generates moker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="289">
                    <text>In addition, the TBC method generates overlapping sequential fragments, as its elimination removes the FHL2 link.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="290">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of Bydented RNase III dyce, but again the relatively small fraction involved and the possibility that long RNAs of 21-23 nt has no was generated by degradation.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="291">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of Bydented RNase III dyce, though again the relatively small fraction involved and the possibility that long RNAs of 21-23 nt have not has been generated by degradation.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="292">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of CTB method, though again the relatively small fraction involved and the possibility that degradation generated no or occurred quickly excluded any definitive conclusion</text>
                    <arg n="0">CTB method</arg>
                </example>
                <example src="PERMUTATE" no="293">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of EE amino acids (437 and 438) for AA, but again the relatively small fraction involved and the possibility that Stat5aEE-AA DNA-binding mutant has no was generated by degradation.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="294">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of EE amino acids (437 and 438) for AA, though again the relatively small fraction involved and the possibility that Stat5aEE-AA DNA-binding mutant would be not generated by degradation.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="295">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of L723 to H3, but again the relatively small fraction involved and the possibility that the correct three-dimensional interaction surface are no generated by degradation.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="296">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of NNOS, although again the relatively small fraction involved and the possibility that superoxide is generated by not for degradation.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="297">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of NNOS, although again the relatively small fraction involved and the possibility that superoxide will be generated by no by degradation.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="298">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of NNOS, though again the relatively small fraction involved and the possibility that superoxide would be not generated by degradation.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="299">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of NONE reacts anaerobically with the purified FNR group FNR, but again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex has no was generated by degradation.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="300">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of NONE reacts anaerobically with the purified FNR group FNR, though again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex are not generated by degradation.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="301">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of NONE reacts anaerobically with the purified FNR group FNR, though again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex would be not generated by degradation.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="302">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of PRnd, but again the relatively small fraction involved and the possibility that main transcripts of 1.7 and 2.7 kb are no generated by degradation.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="303">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of Prnd, although again the relatively small fraction involved and the possibility that main transcripts of 1.7 and 2.7 kb will be generated by no by degradation.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="304">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of Prnd, though again the relatively small fraction involved and the possibility that main transcripts of 1.7 and 2.7 kb have not has been generated by degradation.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="305">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of TBC method, although again the relatively small fraction involved and the possibility that sequential overlapping fragments is generated by not for degradation.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="306">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of TBC method, but again the relatively small fraction involved and the possibility that sequential fragment overlapping are no generated by degradation.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="307">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of TBC method, but again the relatively small fraction involved and the possibility that sequential fragment overlapping has no was generated by degradation.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="308">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of TBC method, but again the relatively small fraction involved and the possibility that sequential superposition fragments are no generated by degradation.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="309">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of TBC method, though again the relatively small fraction involved and the possibility that sequential fragment overlapping are not generated by degradation.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="310">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of TBC method, though again the relatively small fraction involved and the possibility that sequential fragment overlapping would be not generated by degradation.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="311">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of TBC method, though again the relatively small fraction involved and the possibility that sequential overlapping fragments are not generated by degradation.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="312">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of The biceps RNase III Dicer, although again the relatively small fraction involved and the possibility that long mature RNAs of 21-23 nt will be generated by no by degradation.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="313">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of The biceps RNase III Dicer, but again the relatively small fraction involved and the possibility that the 21-23 nt of long mature RNAs are no generated by degradation.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="314">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863 bases RNA chain that occurs in the non-translated region 5, although again the relatively small fraction involved and the possibility that mature hela cell mRNA is generated by not for degradation.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="315">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863 bases RNA chain that occurs in the non-translated region 5, although again the relatively small fraction involved and the possibility that mature hela cell mRNA will be generated by no by degradation.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="316">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-base RNA chunk that occurs in the 5-untranslated region, but again the relatively small fraction involved and the possibility that mature heLa cell mRNA are no generated by degradation.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="317">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-based RNA fragment that occurs in the 5-untranslated region, although again the relatively small fraction involved and the possibility that matur HeLa cell mRNA will be generated by no by degradation.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="318">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-based RNA fragment that occurs in the 5-untranslated region, but again the relatively small fraction involved and the possibility that matur HeLa cell mRNA are no generated by degradation.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="319">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-based RNA fragment that occurs in the 5-untranslated region, but again the relatively small fraction involved and the possibility that matur HeLa cell mRNA would be no generated by degradation.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="320">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a 3863-based RNA fragment that occurs in the 5-untranslated region, though again the relatively small fraction involved and the possibility that matur HeLa cell mRNA are not generated by degradation.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="321">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex, but again the relatively small fraction involved and the possibility that a hypersensitive DNase I has no was generated by degradation.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="322">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex, though again the relatively small fraction involved and the possibility that a hypersensitive chromatin I remodeling complex would be not generated by degradation.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="323">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a SWI/SNF-related chromatin remodeling complex, EKLF 1 reactivation complex, although the relatively small fraction involved and the possibility that degradation had generated no or had occurred quickly excluded any definitive conclusion.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF 1 reactivation complex</arg>
                </example>
                <example src="PERMUTATE" no="324">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1), but again the relatively small fraction involved and the possibility that a hypersensitive to DNase I would be no generated by degradation.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="325">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1), but again the relatively small fraction involved and the possibility that a hypersensitive to DNase I has no was generated by degradation.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="326">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an RNA fragment of 3863 bases occurring in the 5-interpreted region, but again the relatively small fraction involved and the possibility that mRNA of mature HeLa cells has no was generated by degradation.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="327">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of primary gene transcription, but again the relatively small fraction involved and the possibility that HLA has no was generated by degradation.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="328">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of primary gene transcription, but again the relatively small fraction involved and the possibility that HLA would be no generated by degradation.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="329">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of primary genetic transcription, though again the relatively small fraction involved and the possibility that HLA have not has been generated by degradation.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="330">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative coupling of primary transcription of the gene, although again the relatively small fraction involved and the possibility that HLA is generated by not for degradation.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="331">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of biceps RNase III Dicer, although again the relatively small fraction involved and the possibility that 21-23 nt of long mature RNAs is generated by not for degradation.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="332">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of biceps RNase III Dicer, but again the relatively small fraction involved and the possibility that 21-23 nt of long mature RNAs has no was generated by degradation.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="333">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of biceps RNase III Dicer, though again the relatively small fraction involved and the possibility that 21-23 nt of long mature RNAs have not has been generated by degradation.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="334">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of biceps RNase III Dicer, though again the relatively small fraction involved and the possibility that 21-23 nt of long mature RNAs would be not generated by degradation.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="335">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of bidentate RNase III, although again the relatively small fraction involved and the possibility that mature RNA 21-23 nt is generated by not for degradation.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="336">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of bidentate RNase III, but again the relatively small fraction involved and the possibility that mature RNA 21-23 nt would be no generated by degradation.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="337">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of fumat B, although again the relatively small fraction involved and the possibility that fumat will be generated by no by degradation.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="338">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of fumat B, but again the relatively small fraction involved and the possibility that fumat has no was generated by degradation.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="339">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of fumatase B, although again the relatively small fraction involved and the possibility that fumat is generated by not for degradation.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="340">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic slicing with Prnp, although again the relatively small fraction involved and the possibility that some unusual chimeric transcriptions will be generated by no by degradation.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="341">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic slicing with Prnp, but again the relatively small fraction involved and the possibility that some unusual chemical transcriptions would be no generated by degradation.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="342">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic slicing with Prnp, but again the relatively small fraction involved and the possibility that some unusual symmetrical transcriptions has no was generated by degradation.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="343">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic slicing with Prnp, though again the relatively small fraction involved and the possibility that some unusual chemical transcriptions are not generated by degradation.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="344">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic slicing with Prnp, though again the relatively small fraction involved and the possibility that some unusual symmetrical transcriptions would be not generated by degradation.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="345">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic spike with Prnp, but again the relatively small fraction involved and the possibility that some unusual chemical transcriptions would be no generated by degradation.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="346">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of mino mutant acids EE (437 and 438) to AA, although again the relatively small fraction involved and the possibility that the DNA-binding mutant (Stat5aEE-AA) of Stat5a will be generated by no by degradation.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="347">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of mino mutant acids EE (437 and 438) to AA, although the relatively small fraction involved and the possibility that degradation had generated no or had occurred quickly excluded any definitive conclusion.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                </example>
                <example src="PERMUTATE" no="348">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of mino mutant acids EE (437 and 438) to AA, though again the relatively small fraction involved and the possibility that degradation generated no or occurred quickly excluded any definitive conclusion</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                </example>
                <example src="PERMUTATE" no="349">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of muting amino acids EE (437 and 438) to AA, although the relatively small fraction involved and the possibility that degradation had generated no or had occurred quickly excluded any definitive conclusion.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                </example>
                <example src="PERMUTATE" no="350">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of muting amino acids EE (437 and 438) to AA, but again the relatively small fraction involved and the possibility that Stat5aEE-AA would be no generated by degradation.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="351">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of muting amino acids EE (437 and 438) to AA, though again the relatively small fraction involved and the possibility that Stat5aEE-AA have not has been generated by degradation.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="352">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nNOS, although again the relatively small fraction involved and the possibility that superoxide is generated by not for degradation.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="353">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nNOS, although again the relatively small fraction involved and the possibility that suspected is generated by not for degradation.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="354">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of no anaerobic reactions with the purified FNR Fe-S group, though again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex have not has been generated by degradation.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="355">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nodes, although again the relatively small fraction involved and the possibility that monoclonal antibody vs. FHL2 is generated by not for degradation.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="356">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nodes, though again the relatively small fraction involved and the possibility that monoclonal antibody vs. FHL2 are not generated by degradation.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="357">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of nodes, though again the relatively small fraction involved and the possibility that monoclonal antibody vs. FHL2 would be not generated by degradation.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="358">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of none reacts anaerobically with the purified F-S group of FNR, but again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex are no generated by degradation.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="359">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of none reacts anaerobically with the purified F-S group of FNR, though again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex would be not generated by degradation.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="360">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of none reacts anaerobically with the purified FNR group Fe-S, but again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-iron-cystein complex has no was generated by degradation.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="361">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of none reacts anaerobically with the purified FNR group Fe-S, though again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-iron-cystein complex are not generated by degradation.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="362">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of none reacts anaerobically with the purified FNR group Fe-S, though again the relatively small fraction involved and the possibility that spectral changes consistent with the formation of a dinitrosil-iron-cystein complex have not has been generated by degradation.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="363">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of prnd, though again the relatively small fraction involved and the possibility that main transcripts of 1.7 and 2.7 kb are not generated by degradation.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="364">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of proteolysis of amyloid precursor proteins (APP), though again the relatively small fraction involved and the possibility that Abeta peptides are not generated by degradation.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="365">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of proteolysis of amyloid precursor proteins, though again the relatively small fraction involved and the possibility that Abeta peptides have not has been generated by degradation.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="366">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of smoke B, but again the relatively small fraction involved and the possibility that smoke has no was generated by degradation.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="367">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of smoker B, although again the relatively small fraction involved and the possibility that moker will be generated by no by degradation.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="368">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-terminal RA, although again the relatively small fraction involved and the possibility that a functional interaction surface will be generated by no by degradation.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="369">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-terminal RA, but again the relatively small fraction involved and the possibility that a functional interaction surface has no was generated by degradation.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="370">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-terminal RA, though again the relatively small fraction involved and the possibility that a functional interaction surface are not generated by degradation.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="371">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the TBC method, though again the relatively small fraction involved and the possibility that overlapping sequential fragments have not has been generated by degradation.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="372">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the bidentate RNase III Dicer, although again the relatively small fraction involved and the possibility that mature RNA 21-23 nt is generated by not for degradation.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="373">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the bidentate RNase III Dicer, although again the relatively small fraction involved and the possibility that mature RNA 21-23 nt will be generated by no by degradation.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="374">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the bidentate RNase III Dicer, but again the relatively small fraction involved and the possibility that mature RNA 21-23 nt are no generated by degradation.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="375">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the bidentate RNase III Dicer, though again the relatively small fraction involved and the possibility that mature RNA 21-23 nt have not has been generated by degradation.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="376">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the term N-AR, though again the relatively small fraction involved and the possibility that a functional interaction surface would be not generated by degradation.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="377">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the term N-AR, though again the relatively small fraction involved and the possibility that a surface of functional interaction are not generated by degradation.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="378">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the term N-AR, though again the relatively small fraction involved and the possibility that a surface of functional interaction would be not generated by degradation.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="379">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, although again the relatively small fraction involved and the possibility that a higher order DNA-protein complex is generated by not for degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="380">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, but again the relatively small fraction involved and the possibility that a higher DNA complex are no generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="381">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, though again the relatively small fraction involved and the possibility that a higher DNA-protein complex have not has been generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="382">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this binding, though again the relatively small fraction involved and the possibility that high-order DNA protein complex would be not generated by degradation.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="383">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this union, though again the relatively small fraction involved and the possibility that a higher-order protein&#x13;DNA complex are not generated by degradation.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="384">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this union, though again the relatively small fraction involved and the possibility that a higher-order protein&#x13;DNA complex would be not generated by degradation.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="385">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of this union, though again the relatively small fraction involved and the possibility that a higher-order protein-DNA complex would be not generated by degradation.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="386">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of us, although again the relatively small fraction involved and the possibility that monoclonal antibody against FHL2 will be generated by no by degradation.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="387">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of us, although again the relatively small fraction involved and the possibility that monoclonal antibody vs. FHL2 will be generated by no by degradation.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="388">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of us, but again the relatively small fraction involved and the possibility that monoclonal antibody against FHL2 would be no generated by degradation.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="389">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of us, though again the relatively small fraction involved and the possibility that monoclonal antibody against FHL2 have not has been generated by degradation.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="390">
                    <text>In addition, this binding generates high-order DNA protein complex, as its elimination removes the FHL2 link.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="391">
                    <text>In addition, this binding, whose elimination removes the FHL2 link, generates a higher DNA complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="392">
                    <text>In addition, this binding, whose elimination removes the FHL2 link, generates a higher DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="393">
                    <text>In addition, this binding, whose elimination removes the FHL2 link, generates a higher order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="394">
                    <text>In addition, this binding, whose elimination removes the FHL2 link, generates high-order DNA protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="395">
                    <text>In addition, us, whose elimination removes the FHL2 link, generates monoclonal antibody against FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="396">
                    <text>In the absence of L-arginine, 21-23 nt of long mature RNAs (O(2)-) has been generated by biceps RNase III Dicer.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="397">
                    <text>In the absence of L-arginine, Abeta peptides (O(2)-) is generated by proteolysis of amyloid precursor proteins.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="398">
                    <text>In the absence of L-arginine, Abeta peptides (O(2)-) will be generated by proteolysis of amyloid precursor proteins.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="399">
                    <text>In the absence of L-arginine, Bydented RNase III dyce generates long RNAs of 21-23 nt (O(2)-).</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="400">
                    <text>In the absence of L-arginine, HLA (O(2)-) is generated by an alternative coupling of primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="401">
                    <text>In the absence of L-arginine, HLA (O(2)-) was generated by an alternative coupling of primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="402">
                    <text>In the absence of L-arginine, HLA (O(2)-) was generated by an alternative coupling of the primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="403">
                    <text>In the absence of L-arginine, HeLa mature cell mRNA (O(2)-) has been generated by a 3863-base RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="404">
                    <text>In the absence of L-arginine, L723 to H3 generates the correct three-dimensional interaction surface (O(2)-).</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="405">
                    <text>In the absence of L-arginine, PRnd generates main transcripts of 1.7 and 2.7 kb (O(2)-).</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="406">
                    <text>In the absence of L-arginine, Stat5aEE-AA DNA-binding mutant (O(2)-) has been generated by mino EE mutant acids (437 and 438) for AA.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="407">
                    <text>In the absence of L-arginine, Stat5aEE-AA DNA-binding mutant (O(2)-) will be generated by mino EE mutant acids (437 and 438) for AA.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="408">
                    <text>In the absence of L-arginine, TBC method generated sequential overlapping fragments (O(2)-).</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="409">
                    <text>In the absence of L-arginine, TBC method generated sequential superposition fragments (O(2)-).</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="410">
                    <text>In the absence of L-arginine, The biceps RNase III Dicer generates long RNAs of 21-23 nt (O(2)-).</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="411">
                    <text>In the absence of L-arginine, The biceps RNase III Dicer generates the 21-23 nt of long mature RNAs (O(2)-).</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="412">
                    <text>In the absence of L-arginine, a 3863 bases RNA chain that occurs in the non-translated region 5 generated mature hela cell mRNA (O(2)-).</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="413">
                    <text>In the absence of L-arginine, a 3863 bases RNA chain that occurs in the non-translated region 5 generates mature hela cell mRNA (O(2)-).</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="414">
                    <text>In the absence of L-arginine, a 3863-base RNA chunk that occurs in the 5-untranslated region generates mature heLa cell mRNA (O(2)-).</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="415">
                    <text>In the absence of L-arginine, a 3863-base RNA fragment that occurs in the 5-interpreted region generates HeLa mature cell mRNA (O(2)-).</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="416">
                    <text>In the absence of L-arginine, a 3863-base RNA fragment that occurs in the 5-untranslated region generated HeLa mature cell mRNA (O(2)-).</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="417">
                    <text>In the absence of L-arginine, a RNA fragment based on 3863 that occurs in the 5-untranslated region generates mRNA of heLa cells (O(2)-).</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="418">
                    <text>In the absence of L-arginine, a functional interaction surface (O(2)-) will be generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="419">
                    <text>In the absence of L-arginine, a higher DNA complex (O(2)-) has been generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="420">
                    <text>In the absence of L-arginine, a higher order DNA-protein complex (O(2)-) will be generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="421">
                    <text>In the absence of L-arginine, a higher-order protein DNA complex (O(2)-) will be generated by this junction.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="422">
                    <text>In the absence of L-arginine, a higher-order protein-DNA complex (O(2)-) was generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="423">
                    <text>In the absence of L-arginine, a higher-order protein-DNA complex (O(2)-) will be generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="424">
                    <text>In the absence of L-arginine, a hypersensitive DNase I (O(2)-) was generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="425">
                    <text>In the absence of L-arginine, a hypersensitive DNase I (O(2)-) will be generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="426">
                    <text>In the absence of L-arginine, a hypersensitive chromatin I remodeling complex (O(2)-) was generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="427">
                    <text>In the absence of L-arginine, a hypersensitive chromatin I remodeling complex (O(2)-) will be generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="428">
                    <text>In the absence of L-arginine, a hypersensitive to DNase I (O(2)-) has been generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="429">
                    <text>In the absence of L-arginine, a hypersensitive to DNase I (O(2)-) was generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="430">
                    <text>In the absence of L-arginine, an alternative coupling of primary genetic transcription generated HLA (O(2)-).</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="431">
                    <text>In the absence of L-arginine, an alternative coupling of primary genetic transcription generates HLA (O(2)-).</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="432">
                    <text>In the absence of L-arginine, an alternative coupling of primary transcription of the gene generated HLA (O(2)-).</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="433">
                    <text>In the absence of L-arginine, an alternative coupling of primary transcription of the gene generates HLA (O(2)-).</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="434">
                    <text>In the absence of L-arginine, degradation generated specific fragments (O(2)-).</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="435">
                    <text>In the absence of L-arginine, ens generates a monoclonal antibody vs. FHL2 (O(2)-).</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="436">
                    <text>In the absence of L-arginine, fumat B generated fumat (O(2)-).</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="437">
                    <text>In the absence of L-arginine, fumat B generates fumat (O(2)-).</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="438">
                    <text>In the absence of L-arginine, fumatase B generated fumat (O(2)-).</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="439">
                    <text>In the absence of L-arginine, high-order DNA protein complex (O(2)-) has been generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="440">
                    <text>In the absence of L-arginine, high-order protein-DNA complex (O(2)-) is generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="441">
                    <text>In the absence of L-arginine, high-order protein-DNA complex (O(2)-) was generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="442">
                    <text>In the absence of L-arginine, hypersensitive to DNase I (O(2)-) is generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1).</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="443">
                    <text>In the absence of L-arginine, intergenic slicing with Prnp generated some unusual chimeric transcriptions (O(2)-).</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="444">
                    <text>In the absence of L-arginine, large transcriptions of 1.7 and 2.7 kb (O(2)-) was generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="445">
                    <text>In the absence of L-arginine, long RNAs of 21-23 nt (O(2)-) has been generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="446">
                    <text>In the absence of L-arginine, long RNAs of 21-23 nt (O(2)-) is generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="447">
                    <text>In the absence of L-arginine, long RNAs of 21-23 nt (O(2)-) was generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="448">
                    <text>In the absence of L-arginine, mRNA of heLa cells (O(2)-) was generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="449">
                    <text>In the absence of L-arginine, mRNA of mature HeLa cells (O(2)-) was generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="450">
                    <text>In the absence of L-arginine, mRNA of mature HeLa cells (O(2)-) will be generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="451">
                    <text>In the absence of L-arginine, main transcripts of 1.7 and 2.7 kb (O(2)-) has been generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="452">
                    <text>In the absence of L-arginine, main transcripts of 1.7 and 2.7 kb (O(2)-) was generated by PRnd.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="453">
                    <text>In the absence of L-arginine, mature RNA 21-23 nt (O(2)-) is generated by bidentate RNase III.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="454">
                    <text>In the absence of L-arginine, mature RNA 21-23 nt (O(2)-) is generated by the bidentate RNase III Dicer.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="455">
                    <text>In the absence of L-arginine, mino EE mutant acids (437 and 438) for AA generated Stat5aEE-AA DNA-binding mutant (O(2)-).</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="456">
                    <text>In the absence of L-arginine, moker (O(2)-) is generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="457">
                    <text>In the absence of L-arginine, monoclonal antibody against FHL2 (O(2)-) was generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="458">
                    <text>In the absence of L-arginine, monoclonal antibody against FHL2 (O(2)-) will be generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="459">
                    <text>In the absence of L-arginine, nodes generated monoclonal antibody vs. FHL2 (O(2)-).</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="460">
                    <text>In the absence of L-arginine, overlapping sequential fragments (O(2)-) was generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="461">
                    <text>In the absence of L-arginine, prnd generated main transcripts of 1.7 and 2.7 kb (O(2)-).</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="462">
                    <text>In the absence of L-arginine, prnd generates main transcripts of 1.7 and 2.7 kb (O(2)-).</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="463">
                    <text>In the absence of L-arginine, sequential fragment overlapping (O(2)-) has been generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="464">
                    <text>In the absence of L-arginine, sequential overlapping fragments (O(2)-) is generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="465">
                    <text>In the absence of L-arginine, sequential superposition fragments (O(2)-) is generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="466">
                    <text>In the absence of L-arginine, some unusual chemical transcriptions (O(2)-) has been generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="467">
                    <text>In the absence of L-arginine, some unusual chemical transcriptions (O(2)-) has been generated by intergenic spike with Prnp.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="468">
                    <text>In the absence of L-arginine, some unusual chemical transcriptions (O(2)-) is generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="469">
                    <text>In the absence of L-arginine, some unusual chimeric transcriptions (O(2)-) has been generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="470">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex (O(2)-) was generated by NONE reacts anaerobically with the purified FNR group FNR.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="471">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinitrosil-cysteine complex (O(2)-) was generated by None reacts anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="472">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (O(2)-) was generated by no anaerobic reactions with the purified FNR Fe-S group.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="473">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (O(2)-) will be generated by in anaerobically reacted with the purified NR Fe-S cluster.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="474">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (O(2)-) will be generated by no anaerobic reactions with the purified FNR Fe-S group.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="475">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinitrosil-iron-cystein complex (O(2)-) was generated by none reacts anaerobically with the purified FNR group Fe-S.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="476">
                    <text>In the absence of L-arginine, spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex (O(2)-) is generated by none reacts anaerobically with the purified F-S group of FNR.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="477">
                    <text>In the absence of L-arginine, superposed sequential defects (O(2)-) will be generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="478">
                    <text>In the absence of L-arginine, the DNA-binding mutant (Stat5aEE-AA) of Stat5a (O(2)-) has been generated by mino mutant acids EE (437 and 438) to AA.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="479">
                    <text>In the absence of L-arginine, the N-terminal AR generated a functional interaction surface (O(2)-).</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="480">
                    <text>In the absence of L-arginine, the correct three-dimensional interaction surface (O(2)-) is generated by L723 in H3.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="481">
                    <text>In the absence of L-arginine, this binding generated a higher DNA complex (O(2)-).</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="482">
                    <text>In the absence of L-arginine, this binding generated high-order DNA protein complex (O(2)-).</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="483">
                    <text>In the absence of L-arginine, this binding generates a high-order DNA-protein complex (O(2)-).</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="484">
                    <text>In the absence of L-arginine, this binding generates a higher DNA complex (O(2)-).</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="485">
                    <text>In the absence of L-arginine, this union generated a higher-order protein&#x13;DNA complex (O(2)-).</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="486">
                    <text>In the absence of L-arginine, us generates monoclonal antibody vs. FHL2 (O(2)-).</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="487">
                    <text>L723 in H3 can generate the correct three-dimensional interaction surface (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="488">
                    <text>L723 in H3 generated the correct three-dimensional interaction surface (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="489">
                    <text>L723 in H3 generated the correct three-dimensional interaction surface within the recombinant synapse.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="490">
                    <text>L723 in H3 generates the correct three-dimensional interaction surface within the recombinant synapses.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="491">
                    <text>L723 in H3 generates the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="492">
                    <text>L723 in H3 is able to generate the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="493">
                    <text>L723 to H3 generated the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="494">
                    <text>L723 to H3 generates the correct three-dimensional interaction surface (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="495">
                    <text>L723 to H3 is able to generate the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="496">
                    <text>Mino-EE mutant acids (437 and 438) in AA can generate A1 (The DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">Mino-EE mutant acids (437 and 438) in AA</arg>
                </example>
                <example src="PERMUTATE" no="497">
                    <text>Mino-EE mutant acids (437 and 438) in AA generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">Mino-EE mutant acids (437 and 438) in AA</arg>
                </example>
                <example src="PERMUTATE" no="498">
                    <text>Minoan mutants EE (437 and 438) in AA generated A1 (a hypersensitive complex with DNase I.</text>
                    <arg n="0">Minoan mutants EE (437 and 438) in AA</arg>
                </example>
                <example src="PERMUTATE" no="499">
                    <text>Minoan mutants EE (437 and 438) in AA generates A1 (a DNase I hypersensitivity complex.</text>
                    <arg n="0">Minoan mutants EE (437 and 438) in AA</arg>
                </example>
                <example src="PERMUTATE" no="500">
                    <text>NNOS generated superoxide.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="501">
                    <text>NNOS generates superoxide-G molecules of antigen human leukocytes.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="502">
                    <text>NO reacts anaerobicly with the purified NRF Fe-S cluster generated spectral changes consistent with the formation of a dinitrosyl-cysteine complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="503">
                    <text>NO reacts anaerobicly with the purified NRF Fe-S cluster generates spectral changes consistent with the formation of a dinitrosyl-cysteine complex (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="504">
                    <text>NONE reacts anaerobically with the purified FNR group FNR are able to generate spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex .</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="505">
                    <text>NONE reacts anaerobically with the purified FNR group FNR generated spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex within the recombinant synapse.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="506">
                    <text>NONE reacts anaerobically with the purified FNR group FNR generates spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex within the recombinant synapse.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="507">
                    <text>None reacts anaerobically with the purified Fe-S group of NRF can generate spectral changes consistent with the formation of a dinitrosil-cysteine complex (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="508">
                    <text>None reacts anaerobically with the purified Fe-S group of NRF generates spectral changes consistent with the formation of a dinitrosil-cysteine complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="509">
                    <text>PRnd are able to generate main transcripts of 1.7 and 2.7 kb .</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="510">
                    <text>PRnd can generate main transcripts of 1.7 and 2.7 kb (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="511">
                    <text>PRnd generated main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="512">
                    <text>PRnd generates main transcripts of 1.7 and 2.7 kb (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="513">
                    <text>PRnd has generated main transcripts of 1.7 and 2.7 kb for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="514">
                    <text>Prnd can generate main transcripts of 1.7 and 2.7 kb (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="515">
                    <text>Prnd generated large transcriptions of 1.7 and 2.7 kb (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="516">
                    <text>Prnd generated large transcriptions of 1.7 and 2.7 kb-G molecules of human leukocytes.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="517">
                    <text>Prnd generates large transcriptions of 1.7 and 2.7 kb-G molecules of antigen human leukocytes.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="518">
                    <text>Prnd generates large transcriptions of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="519">
                    <text>Prnd generates main transcripts of 1.7 and 2.7 kb (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="520">
                    <text>Prnd generates main transcripts of 1.7 and 2.7 kb-G molecules of antigen human leukocytes.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="521">
                    <text>SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) generated hypersensitive to DNase I for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="522">
                    <text>SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) generated hypersensitive to DNase I-G molecules of human leukocytes.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="523">
                    <text>SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) generated hypersensitive to DNase I.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="524">
                    <text>SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) generates hypersensitive to DNase I (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="525">
                    <text>SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) generates hypersensitive to DNase I within the recombinant synapse.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="526">
                    <text>SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) generates hypersensitive to DNase I.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="527">
                    <text>Stat5aEE-AA DNA-binding mutant (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by EE amino acids (437 and 438) for AA.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="528">
                    <text>Stat5aEE-AA DNA-binding mutant (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by EE amino acids (437 and 438) for AA.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="529">
                    <text>Stat5aEE-AA DNA-binding mutant (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by mino EE mutant acids (437 and 438) for AA.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="530">
                    <text>Stat5aEE-AA DNA-binding mutant are generated by mino EE mutant acids (437 and 438) for AA (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="531">
                    <text>Stat5aEE-AA DNA-binding mutant was generated by EE amino acids (437 and 438) for AA within the recombinant synapse.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="532">
                    <text>Stat5aEE-AA DNA-binding mutant was generated by mino EE mutant acids (437 and 438) for AA (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="533">
                    <text>Stat5aEE-AA DNA-binding mutant will be generated by EE amino acids (437 and 438) for AA. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="534">
                    <text>Stat5aEE-AA DNA-binding mutant will be generated by mino EE mutant acids (437 and 438) for AA.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="535">
                    <text>Stat5aEE-AA can be generated from A0 (amyloid precursor protein proteolysis (APP) by beta and gamma-secretases.</text>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="536">
                    <text>Stat5aEE-AA have been generated from A0 (proteolysis of amyloid precursor proteins (APP) by beta- and gamma-secretases.</text>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="537">
                    <text>Stat5aEE-AA is generated by muting amino acids EE (437 and 438) to AA within the recombinant synapse.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="538">
                    <text>Stat5aEE-AA was generated from A0 (amyloid precursor protein proteolysis (APP) by beta and gamma-secretases.</text>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="539">
                    <text>Stat5aEE-AA were generated by muting amino acids EE (437 and 438) to AA (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="540">
                    <text>TBC method can generate overlapping sequential fragments (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="541">
                    <text>TBC method can generate sequential fragment overlapping.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="542">
                    <text>TBC method generated overlapping sequential fragments-G molecules of human leukocytes.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="543">
                    <text>TBC method generated sequential fragment overlapping.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="544">
                    <text>TBC method generated sequential superposition fragments for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="545">
                    <text>TBC method generated sequential superposition fragments within the recombinant synapse.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="546">
                    <text>TBC method generates overlapping sequential fragments (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="547">
                    <text>TBC method generates sequential fragment overlapping (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="548">
                    <text>TBC method generates sequential fragment overlapping-G molecules of human leukocytes.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="549">
                    <text>TBC method generates sequential fragment overlapping.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="550">
                    <text>TBC method generates sequential overlapping fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="551">
                    <text>TBC method generates sequential superposition fragments within the recombinant synapses.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="552">
                    <text>TBC method is able to generate overlapping sequential fragments .</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="553">
                    <text>TBC method is able to generate sequential fragment overlapping.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="554">
                    <text>TBC method is able to generate sequential superposition fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="555">
                    <text>The Abeta peptides of Stat5a will be generated by proteolysis of amyloid precursor proteins (APP).The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="556">
                    <text>The Abeta peptides-G molecules of human leukocytes were generated by proteolysis of amyloid precursor proteins and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="557">
                    <text>The Bydented RNase III dyce generated the long RNAs of 21-23 nt.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="558">
                    <text>The Bydented RNase III dyce generates the long RNAs of 21-23 nt.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="559">
                    <text>The HLA of Stat5a has been generated by an alternative coupling of primary gene transcription .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="560">
                    <text>The HLA-G molecules are generated by an alternative coupling of primary genetic transcription and show a specialized function in regulating the immune response.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="561">
                    <text>The HLA-G molecules of human leukocytes were generated by an alternative coupling of primary transcription of the gene and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="562">
                    <text>The HeLa mature cell mRNA of Stat5a will be generated by a 3863-base RNA fragment that occurs in the 5-interpreted region.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="563">
                    <text>The HeLa mature cell mRNA-G molecules are generated by a 3863-base RNA fragment that occurs in the 5-untranslated region and show a specialized function in regulating the immune response.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="564">
                    <text>The HeLa mature cell mRNA-G molecules of human leukocytes were generated by a 3863-base RNA fragment that occurs in the 5-untranslated region and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="565">
                    <text>The NO reacts anaerobicly with the purified NRF Fe-S cluster generates the spectral changes consistent with the formation of a dinitrosyl-cysteine complex.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="566">
                    <text>The Prnd generates the main transcripts of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="567">
                    <text>The Stat5aEE-AA DNA-binding mutant of Stat5a will be generated by EE amino acids (437 and 438) for AA.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="568">
                    <text>The Stat5aEE-AA DNA-binding mutant of Stat5a will be generated by mino EE mutant acids (437 and 438) for AA.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="569">
                    <text>The Stat5aEE-AA DNA-binding mutant-G molecules of human leukocytes have been generated by mino EE mutant acids (437 and 438) for AA and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="570">
                    <text>The Stat5aEE-AA DNA-binding mutant-G molecules of human leukocytes were generated by EE amino acids (437 and 438) for AA and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="571">
                    <text>The Stat5aEE-AA DNA-binding mutant-G molecules of human leukocytes were generated by mino EE mutant acids (437 and 438) for AA and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="572">
                    <text>The Stat5aEE-AA-G molecules of human leukocytes were generated by muting amino acids EE (437 and 438) to AA and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="573">
                    <text>The TBC method generated the sequential fragment overlapping.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="574">
                    <text>The a 3863 bases RNA chain that occurs in the non-translated region 5 generated the mature hela cell mRNA.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="575">
                    <text>The a 3863-base RNA chunk that occurs in the 5-untranslated region generated the mature heLa cell mRNA.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="576">
                    <text>The a functional interaction surface-G molecules of human leukocytes have been generated by the term N-AR and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="577">
                    <text>The a functional interaction surface-G molecules of human leukocytes were generated by the N-terminal RA and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="578">
                    <text>The a functional interaction surface-G molecules of human leukocytes were generated by the term N-AR and had a specialized function in regulating the immune response.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="579">
                    <text>The a high-order DNA-protein complex-G molecules of human leukocytes have been generated by this binding and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="580">
                    <text>The a higher DNA-protein complex-G molecules of human leukocytes were generated by this binding and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="581">
                    <text>The a higher-order protein&#x13;DNA complex of Stat5a has been generated by this union .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="582">
                    <text>The a higher-order protein&#x13;DNA complex-G molecules are generated by this union and show a specialized function in regulating the immune response.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="583">
                    <text>The a higher-order protein-DNA complex-G molecules of human leukocytes were generated by this union and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="584">
                    <text>The a hypersensitive DNase I of Stat5a has been generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="585">
                    <text>The a hypersensitive to DNase I of Stat5a has been generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="586">
                    <text>The a hypersensitive to DNase I of Stat5a will be generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1).The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="587">
                    <text>The a hypersensitive to DNase I of Stat5a will be generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1).The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="588">
                    <text>The a hypersensitive to DNase I-G molecules of human leukocytes have been generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="589">
                    <text>The a hypersensitive to DNase I-G molecules of human leukocytes were generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="590">
                    <text>The a monoclonal antibody vs. FHL2 of Stat5a has been generated by ens .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="591">
                    <text>The a monoclonal antibody vs. FHL2-G molecules of human leukocytes have been generated by ens and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="592">
                    <text>The a monoclonal antibody vs. FHL2-G molecules of human leukocytes were generated by ens and had a specialized function in regulating the immune response.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="593">
                    <text>The a surface of functional interaction-G molecules of human leukocytes have been generated by the term N-AR and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="594">
                    <text>The abeta peptides of Stat5a is generated by A0 (muting amino acids EE (437 and 438) for AA.</text>
                    <arg n="1">abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="595">
                    <text>The an RNA fragment of 3863 bases occurring in the 5-interpreted region generates the mRNA of mature HeLa cells.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="596">
                    <text>The an alternative coupling of primary genetic transcription generates the HLA.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="597">
                    <text>The biceps RNase III Dicer can generate long RNAs of 21-23 nt (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="598">
                    <text>The biceps RNase III Dicer can generate the 21-23 nt of long mature RNAs.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="599">
                    <text>The biceps RNase III Dicer generated long RNAs of 21-23 nt-G molecules of human leukocytes.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="600">
                    <text>The biceps RNase III Dicer generates long RNAs of 21-23 nt (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="601">
                    <text>The biceps RNase III Dicer generates long RNAs of 21-23 nt within the recombinant synapse.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="602">
                    <text>The biceps RNase III Dicer generates long RNAs of 21-23 nt-G molecules of antigen human leukocytes.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="603">
                    <text>The biceps RNase III Dicer generates long mature RNAs of 21-23 nt within the recombinant synapse.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="604">
                    <text>The bidentate RNase III generates the mature RNA 21-23 nt.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="605">
                    <text>The fumat of Stat5a will be generated by fumat B.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="606">
                    <text>The fumat-G molecules of human leukocytes have been generated by fumat B and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="607">
                    <text>The fumat-G molecules of human leukocytes have been generated by fumatase B and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="608">
                    <text>The fumat-G molecules of human leukocytes were generated by fumatase B and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="609">
                    <text>The fumatase B generates the fumat.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="610">
                    <text>The high-order DNA protein complex-G molecules of human leukocytes were generated by this binding and had a specialized function in regulating the immune response.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="611">
                    <text>The high-order DNA-protein complex-G molecules of human leukocytes were generated by this binding and had a specialized function in regulating the immune response.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="612">
                    <text>The high-order protein-DNA complex-G molecules of human leukocytes were generated by this union and had a specialized function in regulating the immune response.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="613">
                    <text>The large transcriptions of 1.7 and 2.7 kb of Stat5a has been generated by Prnd .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="614">
                    <text>The long RNAs of 21-23 nt of Stat5a has been generated by The biceps RNase III Dicer .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="615">
                    <text>The long mature RNAs of 21-23 nt of Stat5a will be generated by The biceps RNase III Dicer.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="616">
                    <text>The mRNA of heLa cells-G molecules of human leukocytes were generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region and had a specialized function in regulating the immune response.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="617">
                    <text>The mRNA of heLa cells-G molecules of human leukocytes were generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="618">
                    <text>The main transcripts of 1.7 and 2.7 kb of Stat5a has been generated by PRnd .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="619">
                    <text>The main transcripts of 1.7 and 2.7 kb of Stat5a will be generated by PRnd.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="620">
                    <text>The main transcripts of 1.7 and 2.7 kb of Stat5a will be generated by Prnd.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="621">
                    <text>The main transcripts of 1.7 and 2.7 kb-G molecules of human leukocytes were generated by Prnd and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="622">
                    <text>The main transcripts of 1.7 and 2.7 kb-G molecules of human leukocytes were generated by prnd and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="623">
                    <text>The matur HeLa cell mRNA-G molecules of human leukocytes were generated by a 3863-based RNA fragment that occurs in the 5-untranslated region and had a specialized function in regulating the immune response.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="624">
                    <text>The mature RNA 21-23 nt of Stat5a has been generated by the bidentate RNase III Dicer .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="625">
                    <text>The mature RNA 21-23 nt-G molecules of human leukocytes have been generated by the bidentate RNase III Dicer and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="626">
                    <text>The mature RNA 21-23 nt-G molecules of human leukocytes were generated by the bidentate RNase III Dicer and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="627">
                    <text>The mature hela cell mRNA of Stat5a will be generated by a 3863 bases RNA chain that occurs in the non-translated region 5.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="628">
                    <text>The moker of Stat5a has been generated by smoker B .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="629">
                    <text>The moker of Stat5a will be generated by smoker B.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="630">
                    <text>The monoclonal antibody against FHL2-G molecules are generated by us and show a specialized function in regulating the immune response.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="631">
                    <text>The monoclonal antibody against FHL2-G molecules of human leukocytes were generated by us and had a specialized function in regulating the immune response.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="632">
                    <text>The monoclonal antibody against FHL2-G molecules of human leukocytes were generated by us and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="633">
                    <text>The monoclonal antibody against FHL2-G molecules of human leukocytes were generated by us and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="634">
                    <text>The monoclonal antibody vs. FHL2-G molecules of human leukocytes were generated by nodes and had a specialized function in regulating the immune response.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="635">
                    <text>The nNOS generates the suspected.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="636">
                    <text>The none reacts anaerobically with the purified FNR group Fe-S generates the spectral changes consistent with the formation of a dinitrosil-iron-cystein complex.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="637">
                    <text>The overlapping sequential fragments-G molecules of human leukocytes were generated by the TBC method and had a specialized function in regulating the immune response.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="638">
                    <text>The proteolysis of amyloid precursor proteins (APP) generated the Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="639">
                    <text>The sequential fragment overlapping of Stat5a has been generated by TBC method .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="640">
                    <text>The sequential overlapping fragments-G molecules are generated by TBC method and show a specialized function in regulating the immune response.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="641">
                    <text>The sequential superposition fragments of Stat5a has been generated by TBC method .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="642">
                    <text>The smoke B generates the smoke.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="643">
                    <text>The smoker B generated the moker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="644">
                    <text>The smoker B generated the motor.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="645">
                    <text>The smoker-G molecules of human leukocytes were generated by smoker B and had a specialized function in regulating the immune response.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="646">
                    <text>The smoker-G molecules of human leukocytes were generated by smoker B and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="647">
                    <text>The some unusual chemical transcriptions-G molecules are generated by intergenic slicing with Prnp and show a specialized function in regulating the immune response.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="648">
                    <text>The some unusual chimeric transcriptions-G molecules of human leukocytes have been generated by intergenic slicing with Prnp and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="649">
                    <text>The some unusual chimeric transcriptions-G molecules of human leukocytes were generated by intergenic slicing with Prnp and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="650">
                    <text>The some unusual symmetrical transcriptions of Stat5a will be generated by intergenic slicing with Prnp.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="651">
                    <text>The spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex of Stat5a has been generated by NONE reacts anaerobically with the purified FNR group FNR .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="652">
                    <text>The spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex of Stat5a will be generated by NONE reacts anaerobically with the purified FNR group FNR.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="653">
                    <text>The spectral changes consistent with the formation of a dinitrosil-cysteine complex of Stat5a will be generated by None reacts anaerobically with the purified Fe-S group of NRF.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="654">
                    <text>The spectral changes consistent with the formation of a dinitrosil-cysteine complex-G molecules of human leukocytes have been generated by does not react anaerobically with the purified Fe-S group of NRF and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="655">
                    <text>The spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex of Stat5a will be generated by no anaerobic reactions with the purified FNR Fe-S group.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="656">
                    <text>The spectral changes consistent with the formation of a dinitrosil-iron-cystein complex of Stat5a has been generated by none reacts anaerobically with the purified FNR group Fe-S .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="657">
                    <text>The spectral changes consistent with the formation of a dinitrosil-iron-cystein complex-G molecules of human leukocytes were generated by none reacts anaerobically with the purified FNR group Fe-S and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="658">
                    <text>The spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex-G molecules of human leukocytes have been generated by none reacts anaerobically with the purified F-S group of FNR and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="659">
                    <text>The spectral changes consistent with the formation of a dinitrosyl-cysteine complex of Stat5a will be generated by NO reacts anaerobicly with the purified NRF Fe-S cluster.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="660">
                    <text>The spectral changes consistent with the formation of a dinitrosyl-cysteine complex-G molecules of human leukocytes have been generated by NO reacts anaerobicly with the purified NRF Fe-S cluster and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="661">
                    <text>The superoxide of Stat5a will be generated by NNOS.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="662">
                    <text>The superoxide-G molecules of human leukocytes were generated by nNOS and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="663">
                    <text>The superposed sequential defects of Stat5a has been generated by the TBC method .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="664">
                    <text>The superposed sequential defects-G molecules of human leukocytes were generated by the TBC method and had a specialized function in regulating the immune response.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="665">
                    <text>The superposed sequential defects-G molecules of human leukocytes were generated by the TBC method and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="666">
                    <text>The suspected-G molecules of human leukocytes were generated by nNOS and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="667">
                    <text>The the DNA-binding mutant (Stat5aEE-AA) of Stat5a-G molecules of human leukocytes were generated by mino mutant acids EE (437 and 438) to AA and had a specialized function in regulating the immune response.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="668">
                    <text>The the DNA-binding mutant (Stat5aEE-AA) of Stat5a-G molecules of human leukocytes were generated by mino mutant acids EE (437 and 438) to AA and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="669">
                    <text>The the bidentate RNase III Dicer generated the mature RNA 21-23 nt.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="670">
                    <text>The the correct three-dimensional interaction surface of Stat5a has been generated by L723 in H3 .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="671">
                    <text>The this union generates the a higher-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="672">
                    <text>The us generated the monoclonal antibody against FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="673">
                    <text>These are Abeta peptides reductase (coded by the operon of frdABCD), proteolysis of amyloid precursor proteins (APP), which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="674">
                    <text>These are Abeta peptides reductase (encoded by the operon frdABCD), proteolysis of amyloid precursor proteins (APP), which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="675">
                    <text>These are HLA reductase (coded by the operon of frdABCD), an alternative coupling of primary gene transcription, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="676">
                    <text>These are HLA reductase (coded by the operon of frdABCD), an alternative coupling of primary gene transcription, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="677">
                    <text>These are HLA reductase (encoded by the operon frdABCD), an alternative coupling of primary gene transcription, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="678">
                    <text>These are HLA reductase (encoded by the operon frdABCD), an alternative coupling of primary genetic transcription, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="679">
                    <text>These are HLA reductase (encoded by the operon frdABCD), an alternative coupling of primary genetic transcription, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="680">
                    <text>These are HLA reductase (encoded by the operon frdABCD), an alternative coupling of primary transcription of the gene, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="681">
                    <text>These are Stat5aEE-AA DNA-binding mutant reductase (encoded by the operon frdABCD), EE amino acids (437 and 438) for AA, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="682">
                    <text>These are Stat5aEE-AA DNA-binding mutant reductase (encoded by the operon frdABCD), mino EE mutant acids (437 and 438) for AA, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="683">
                    <text>These are a functional interaction surface reductase (encoded by the operon frdABCD), the N-terminal AR, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="684">
                    <text>These are a functional interaction surface reductase (encoded by the operon frdABCD), the N-terminal AR, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="685">
                    <text>These are a functional interaction surface reductase (encoded by the operon frdABCD), the N-terminal RA, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="686">
                    <text>These are a functional interaction surface reductase (encoded by the operon frdABCD), the N-terminal RA, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="687">
                    <text>These are a functional interaction surface reductase (encoded by the operon frdABCD), the N-terminal RA, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="688">
                    <text>These are a higher DNA complex reductase (coded by the operon of frdABCD), this binding, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="689">
                    <text>These are a higher-order protein&#x13;DNA complex reductase (encoded by the operon frdABCD), this union, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="690">
                    <text>These are a higher-order protein DNA complex reductase (encoded by the operon frdABCD), this junction, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="691">
                    <text>These are a higher-order protein-DNA complex reductase (coded by the operon of frdABCD), this union, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="692">
                    <text>These are a hypersensitive DNase I reductase (coded by the operon of frdABCD), a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="693">
                    <text>These are a hypersensitive chromatin I remodeling complex reductase (encoded by the operon frdABCD), a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="694">
                    <text>These are a hypersensitive to DNase I reductase (coded by the operon of frdABCD), a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1), which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="695">
                    <text>These are a hypersensitive to DNase I reductase (encoded by the operon frdABCD), a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1), which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="696">
                    <text>These are a surface of functional interaction reductase (coded by the operon of frdABCD), the term N-AR, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="697">
                    <text>These are high-order DNA-protein complex reductase (encoded by the operon frdABCD), this binding, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="698">
                    <text>These are hypersensitive to DNase I reductase (encoded by the operon frdABCD), SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1), which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="699">
                    <text>These are large transcriptions of 1.7 and 2.7 kb reductase (encoded by the operon frdABCD), Prnd, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="700">
                    <text>These are long RNAs of 21-23 nt reductase (coded by the operon of frdABCD), The biceps RNase III Dicer, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="701">
                    <text>These are long RNAs of 21-23 nt reductase (encoded by the operon frdABCD), Bydented RNase III dyce, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="702">
                    <text>These are long RNAs of 21-23 nt reductase (encoded by the operon frdABCD), Bydented RNase III dyce, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="703">
                    <text>These are long RNAs of 21-23 nt reductase (encoded by the operon frdABCD), The biceps RNase III Dicer, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="704">
                    <text>These are long mature RNAs of 21-23 nt reductase (encoded by the operon frdABCD), The biceps RNase III Dicer, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="705">
                    <text>These are mRNA of mature HeLa cells reductase (encoded by the operon frdABCD), an RNA fragment of 3863 bases occurring in the 5-interpreted region, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="706">
                    <text>These are matur HeLa cell mRNA reductase (encoded by the operon frdABCD), a 3863-based RNA fragment that occurs in the 5-untranslated region, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="707">
                    <text>These are matur HeLa cell mRNA reductase (encoded by the operon frdABCD), a 3863-based RNA fragment that occurs in the 5-untranslated region, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="708">
                    <text>These are mature RNA 21-23 nt reductase (coded by the operon of frdABCD), bidentate RNase III, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="709">
                    <text>These are mature RNA 21-23 nt reductase (encoded by the operon frdABCD), the bidentate RNase III Dicer, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="710">
                    <text>These are mature RNA 21-23 nt reductase (encoded by the operon frdABCD), the bidentate RNase III Dicer, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="711">
                    <text>These are mature hela cell mRNA reductase (encoded by the operon frdABCD), a 3863 bases RNA chain that occurs in the non-translated region 5, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="712">
                    <text>These are moker reductase (coded by the operon of frdABCD), smoker B, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="713">
                    <text>These are monoclonal antibody against FHL2 reductase (coded by the operon of frdABCD), us, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="714">
                    <text>These are monoclonal antibody against FHL2 reductase (encoded by the operon frdABCD), us, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="715">
                    <text>These are monoclonal antibody vs. FHL2 reductase (coded by the operon of frdABCD), nodes, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="716">
                    <text>These are motor reductase (coded by the operon of frdABCD), smoker B, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="717">
                    <text>These are motor reductase (encoded by the operon frdABCD), smoker B, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="718">
                    <text>These are sequential fragment overlapping reductase (encoded by the operon frdABCD), TBC method, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="719">
                    <text>These are sequential overlapping fragments reductase (coded by the operon of frdABCD), TBC method, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="720">
                    <text>These are sequential superposition fragments reductase (encoded by the operon frdABCD), TBC method, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="721">
                    <text>These are smoker reductase (encoded by the operon frdABCD), smoker B, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="722">
                    <text>These are some unusual chemical transcriptions reductase (encoded by the operon frdABCD), intergenic slicing with Prnp, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="723">
                    <text>These are specific fragments reductase (coded by the operon of frdABCD), degradation, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="724">
                    <text>These are specific fragments reductase (encoded by the operon frdABCD), degradation, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="725">
                    <text>These are specific fragments reductase (encoded by the operon frdABCD), degradation, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="726">
                    <text>These are spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex reductase (encoded by the operon frdABCD), NONE reacts anaerobically with the purified FNR group FNR, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="727">
                    <text>These are spectral changes consistent with the formation of a dinitrosil-cysteine complex reductase (coded by the operon of frdABCD), None reacts anaerobically with the purified Fe-S group of NRF, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="728">
                    <text>These are spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex reductase (coded by the operon of frdABCD), no anaerobic reactions with the purified FNR Fe-S group, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="729">
                    <text>These are spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex reductase (encoded by the operon frdABCD), in anaerobically reacted with the purified NR Fe-S cluster, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="730">
                    <text>These are spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex reductase (encoded by the operon frdABCD), no anaerobic reactions with the purified FNR Fe-S group, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="731">
                    <text>These are spectral changes consistent with the formation of a dinitrosyl-cysteine complex reductase (coded by the operon of frdABCD), NO reacts anaerobicly with the purified NRF Fe-S cluster, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="732">
                    <text>These are spectral changes consistent with the formation of a dinitrosyl-cysteine complex reductase (encoded by the operon frdABCD), NO reacts anaerobicly with the purified NRF Fe-S cluster, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="733">
                    <text>These are spectral changes consistent with the formation of a dinitrosyl-cysteine complex reductase (encoded by the operon frdABCD), NO reacts anaerobicly with the purified NRF Fe-S cluster, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="734">
                    <text>These are superoxide reductase (coded by the operon of frdABCD), NNOS, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="735">
                    <text>These are superoxide reductase (encoded by the operon frdABCD), NNOS, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="736">
                    <text>These are superoxide reductase (encoded by the operon frdABCD), NNOS, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="737">
                    <text>These are superposed sequential defects reductase (encoded by the operon frdABCD), the TBC method, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="738">
                    <text>These are the 21-23 nt of long mature RNAs reductase (encoded by the operon frdABCD), The biceps RNase III Dicer, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="739">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, Abeta peptides is generated by proteolysis of amyloid precursor proteins (APP).</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="740">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, HLA is generated by an alternative coupling of primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="741">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, HLA is generated by an alternative coupling of the primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="742">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, a higher DNA-protein complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="743">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, high-order DNA-protein complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="744">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, high-order protein-DNA complex is generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="745">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, large transcriptions of 1.7 and 2.7 kb is generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="746">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, main transcripts of 1.7 and 2.7 kb is generated by prnd.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="747">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, sequential fragment overlapping is generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="748">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, spectral changes consistent with the formation of a dinitrosil-iron-cystein complex is generated by none reacts anaerobically with the purified FNR group Fe-S.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="749">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, spectral changes consistent with the formation of a dinitrosyl-cysteine complex is generated by NO reacts anaerobicly with the purified NRF Fe-S cluster.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="750">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, suspected is generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="751">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, EE amino acids (437 and 438) for AA will generate Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="752">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, HeLa mature cell mRNA is generated by a 3863-base RNA fragment that occurs in the 5-interpreted region.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="753">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, L723 in H3 will generate the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="754">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, NNOS will generate superoxide.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="755">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, NONE reacts anaerobically with the purified FNR group FNR generates spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="756">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, Stat5aEE-AA DNA-binding mutant is generated by EE amino acids (437 and 438) for AA.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="757">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, TBC method generates overlapping sequential fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="758">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, The biceps RNase III Dicer generates long RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="759">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, The biceps RNase III Dicer will generate the 21-23 nt of long mature RNAs.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="760">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a 3863 bases RNA chain that occurs in the non-translated region 5 will generate mature hela cell mRNA.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="761">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a 3863-based RNA fragment that occurs in the 5-untranslated region will generate matur HeLa cell mRNA.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="762">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) will generate a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="763">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a functional interaction surface is generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="764">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a functional interaction surface is generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="765">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a hypersensitive chromatin I remodeling complex is generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="766">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, an alternative coupling of primary genetic transcription will generate HLA.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="767">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, degradation generates specific fragments.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="768">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, fumatase B will generate fumat.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="769">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, intergenic slicing with Prnp generates some unusual symmetrical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="770">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, long RNAs of 21-23 nt is generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="771">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, mino EE mutant acids (437 and 438) for AA will generate Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="772">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, mino mutant acids EE (437 and 438) to AA generates the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="773">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, monoclonal antibody against FHL2 is generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="774">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, nNOS generates suspected.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="775">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, no anaerobic reactions with the purified FNR Fe-S group will generate spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="776">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, none reacts anaerobically with the purified F-S group of FNR will generate spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="777">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, none reacts anaerobically with the purified FNR group Fe-S generates spectral changes consistent with the formation of a dinitrosil-iron-cystein complex.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="778">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, proteolysis of amyloid precursor proteins will generate Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="779">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, sequential overlapping fragments is generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="780">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, smoke B will generate smoke.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="781">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, smoker B generates moker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="782">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, smoker B generates motor.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="783">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, smoker B will generate motor.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="784">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, smoker B will generate smoker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="785">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex is generated by no anaerobic reactions with the purified FNR Fe-S group.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="786">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, superoxide is generated by NNOS.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="787">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, the TBC method will generate overlapping sequential fragments.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="788">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, the correct three-dimensional interaction surface is generated by L723 in H3.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="789">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, this binding generates a high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="790">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, this binding generates a higher order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="791">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, this union generates high-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="792">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, this union will generate high-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="793">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, HLA was generated by an alternative coupling of primary gene transcription.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="794">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, a higher order DNA-protein complex was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="795">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, a higher-order protein&#x13;DNA complex was generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="796">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, a higher-order protein-DNA complex was generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="797">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, a hypersensitive to DNase I was generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="798">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, a hypersensitive to DNase I was generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="799">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, fumat was generated by fumatase B.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="800">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, high-order DNA protein complex was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="801">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, main transcripts of 1.7 and 2.7 kb was generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="802">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, mature heLa cell mRNA was generated by a 3863-base RNA chunk that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="803">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, mature hela cell mRNA was generated by a 3863 bases RNA chain that occurs in the non-translated region 5.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="804">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex was generated by NONE reacts anaerobically with the purified FNR group FNR.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="805">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, spectral changes consistent with the formation of a dinitrosil-iron-cystein complex was generated by none reacts anaerobically with the purified FNR group Fe-S.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="806">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex was generated by none reacts anaerobically with the purified F-S group of FNR.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="807">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, the correct three-dimensional interaction surface was generated by L723 in H3.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="808">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) can generate hypersensitive to DNase I.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="809">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues an alternative coupling of primary transcription of the gene can generate HLA.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="810">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues mino EE mutant acids (437 and 438) for AA can generate Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="811">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues nodes can generate monoclonal antibody against FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="812">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues nodes can generate monoclonal antibody vs. FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="813">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues proteolysis of amyloid precursor proteins can generate Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="814">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues the N-terminal AR can generate a functional interaction surface.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="815">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues the TBC method can generate superposed sequential defects.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="816">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues this binding can generate a high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="817">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues this binding can generate a higher DNA complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="818">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues this union can generate a higher-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="819">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, EE amino acids (437 and 438) for AA may generate Stat5aEE-AA DNA-binding mutant.</text>
                    <arg n="0">EE amino acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="820">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, HLA was generated by an alternative coupling of the primary transcription of the gene.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="821">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, L723 in H3 will generate the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="822">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, L723 to H3 may generate the correct three-dimensional interaction surface.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="823">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, NNOS will generate superoxide.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="824">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, NONE reacts anaerobically with the purified FNR group FNR may generate spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="825">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, Prnd may generate large transcriptions of 1.7 and 2.7 kb.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="826">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, Stat5aEE-AA DNA-binding mutant was generated by mino EE mutant acids (437 and 438) for AA.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="827">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, TBC method may generate sequential overlapping fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="828">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, TBC method will generate overlapping sequential fragments.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="829">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, The biceps RNase III Dicer generates long RNAs of 21-23 nt .</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="830">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, The biceps RNase III Dicer may generate long RNAs of 21-23 nt.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="831">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a 3863 bases RNA chain that occurs in the non-translated region 5 may generate mature hela cell mRNA.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="832">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a 3863-base RNA chunk that occurs in the 5-untranslated region may generate mature heLa cell mRNA.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="833">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a RNA fragment based on 3863 that occurs in the 5-untranslated region generates mRNA of heLa cells .</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="834">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) will generate a hypersensitive to DNase I.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="835">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a functional interaction surface was generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="836">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, a higher DNA-protein complex was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="837">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, an RNA fragment of 3863 bases occurring in the 5-interpreted region generates mRNA of mature HeLa cells .</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="838">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, an RNA fragment of 3863 bases occurring in the 5-interpreted region will generate mRNA of mature HeLa cells.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="839">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, an alternative coupling of primary genetic transcription may generate HLA.</text>
                    <arg n="0">an alternative coupling of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="840">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, an alternative coupling of primary transcription of the gene may generate HLA.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="841">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, an alternative coupling of the primary transcription of the gene generates HLA .</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="842">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, bidentate RNase III will generate mature RNA 21-23 nt.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="843">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, degradation will generate specific fragments.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="844">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, ens generates a monoclonal antibody vs. FHL2 .</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="845">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, fumat was generated by fumatase B.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="846">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, fumatase B generates fumat .</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="847">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, fumatase B may generate fumat.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="848">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, long RNAs of 21-23 nt was generated by Bydented RNase III dyce.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="849">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, mRNA of mature HeLa cells was generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="850">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, mature hela cell mRNA was generated by a 3863 bases RNA chain that occurs in the non-translated region 5.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="851">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, monoclonal antibody vs. FHL2 was generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="852">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, none reacts anaerobically with the purified F-S group of FNR may generate spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="853">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, none reacts anaerobically with the purified F-S group of FNR will generate spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="854">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, proteolysis of amyloid precursor proteins will generate Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="855">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, smoker B will generate smoker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="856">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, superposed sequential defects was generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="857">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, the TBC method may generate overlapping sequential fragments.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="858">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, the term N-AR may generate a functional interaction surface.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="859">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, the term N-AR may generate a surface of functional interaction.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="860">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, this binding generates a higher DNA-protein complex .</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="861">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, this binding generates high-order DNA-protein complex .</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="862">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, this binding may generate a high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="863">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, this binding may generate a higher order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="864">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, this binding may generate high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="865">
                    <text>We believe that Bydented RNase III dyce is shown to generate long RNAs of 21-23 nt within the reombine synapses.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="866">
                    <text>We believe that L723 to H3 is able to generate the correct three-dimensional interaction surface within the recombinant synapse.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="867">
                    <text>We believe that L723 to H3 is able to generate the correct three-dimensional interaction surface within the reombian synapses.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="868">
                    <text>We believe that NNOS is shown to generate superoxide within the reombine synapses.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="869">
                    <text>We believe that SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) is shown to generate hypersensitive to DNase I within the reombine synapses.</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="870">
                    <text>We believe that TBC method is shown to generate overlapping sequential fragments within the reombine synapses.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="871">
                    <text>We believe that TBC method is shown to generate sequential overlapping fragments within the reombine synapses.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="872">
                    <text>We believe that The biceps RNase III Dicer is shown to generate long RNAs of 21-23 nt within the reombine synapses.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="873">
                    <text>We believe that a 3863 bases RNA chain that occurs in the non-translated region 5 is able to generate mature hela cell mRNA within the recombinant synapse.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="874">
                    <text>We believe that a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex is able to generate a hypersensitive chromatin I remodeling complex within the reombian synapses.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="875">
                    <text>We believe that a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) is shown to generate a hypersensitive to DNase I within the reombine synapses.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="876">
                    <text>We believe that a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) is able to generate a hypersensitive to DNase I within the recombinant synapse.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="877">
                    <text>We believe that an RNA fragment of 3863 bases occurring in the 5-interpreted region is able to generate mRNA of mature HeLa cells within the reombian synapses.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="878">
                    <text>We believe that an alternative coupling of primary gene transcription is shown to generate HLA within the reombine synapses.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="879">
                    <text>We believe that biceps RNase III Dicer is able to generate 21-23 nt of long mature RNAs within the reombian synapses.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="880">
                    <text>We believe that bidentate RNase III is able to generate mature RNA 21-23 nt within the reombian synapses.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="881">
                    <text>We believe that bidentate RNase III is shown to generate mature RNA 21-23 nt within the reombine synapses.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="882">
                    <text>We believe that degradation is able to generate specific fragments within the recombinant synapse.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="883">
                    <text>We believe that does not react anaerobically with the purified Fe-S group of NRF is able to generate spectral changes consistent with the formation of a dinitrosil-cysteine complex within the reombian synapses.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="884">
                    <text>We believe that ens is able to generate a monoclonal antibody vs. FHL2 within the recombinant synapse.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="885">
                    <text>We believe that ens is able to generate a monoclonal antibody vs. FHL2 within the reombian synapses.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="886">
                    <text>We believe that intergenic slicing with Prnp is able to generate some unusual chimeric transcriptions within the recombinant synapse.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="887">
                    <text>We believe that intergenic slicing with Prnp is able to generate some unusual symmetrical transcriptions within the reombian synapses.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="888">
                    <text>We believe that mino EE mutant acids (437 and 438) for AA is able to generate Stat5aEE-AA DNA-binding mutant within the recombinant synapse.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="889">
                    <text>We believe that muting amino acids EE (437 and 438) to AA is able to generate Stat5aEE-AA within the reombian synapses.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="890">
                    <text>We believe that nNOS is able to generate suspected within the recombinant synapse.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="891">
                    <text>We believe that no anaerobic reactions with the purified FNR Fe-S group is able to generate spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex within the reombian synapses.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="892">
                    <text>We believe that nodes is able to generate monoclonal antibody vs. FHL2 within the recombinant synapse.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="893">
                    <text>We believe that prnd is able to generate main transcripts of 1.7 and 2.7 kb within the recombinant synapse.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="894">
                    <text>We believe that proteolysis of amyloid precursor proteins (APP) is able to generate Abeta peptides within the recombinant synapse.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="895">
                    <text>We believe that smoker B is able to generate moker within the recombinant synapse.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="896">
                    <text>We believe that smoker B is able to generate smoker within the reombian synapses.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="897">
                    <text>We believe that the TBC method is able to generate overlapping sequential fragments within the recombinant synapse.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="898">
                    <text>We believe that the bidentate RNase III Dicer is shown to generate mature RNA 21-23 nt within the reombine synapses.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="899">
                    <text>We believe that the term N-AR is able to generate a functional interaction surface within the reombian synapses.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="900">
                    <text>We believe that this binding is able to generate a higher DNA-protein complex within the reombian synapses.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="901">
                    <text>We believe that us is able to generate monoclonal antibody against FHL2 within the reombian synapses.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="902">
                    <text>a 3863 bases RNA chain that occurs in the non-translated region 5 can generate mature hela cell mRNA (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="903">
                    <text>a 3863 bases RNA chain that occurs in the non-translated region 5 can generate mature hela cell mRNA.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="904">
                    <text>a 3863 bases RNA chain that occurs in the non-translated region 5 generates mature hela cell mRNA (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="905">
                    <text>a 3863 bases RNA chain that occurs in the non-translated region 5 generates mature hela cell mRNA (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="906">
                    <text>a 3863 bases RNA chain that occurs in the non-translated region 5 generates mature hela cell mRNA within the recombinant synapse.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="907">
                    <text>a 3863 bases RNA chain that occurs in the non-translated region 5 has generated mature hela cell mRNA for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="908">
                    <text>a 3863 bases RNA chain that occurs in the non-translated region 5 is able to generate mature hela cell mRNA .</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="909">
                    <text>a 3863-base RNA chunk that occurs in the 5-untranslated region can generate mature heLa cell mRNA (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="910">
                    <text>a 3863-base RNA chunk that occurs in the 5-untranslated region generated mature heLa cell mRNA.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="911">
                    <text>a 3863-base RNA chunk that occurs in the 5-untranslated region generates mature heLa cell mRNA (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="912">
                    <text>a 3863-base RNA chunk that occurs in the 5-untranslated region generates mature heLa cell mRNA within the recombinant synapse.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="913">
                    <text>a 3863-base RNA fragment that occurs in the 5-interpreted region generates HeLa mature cell mRNA within the recombinant synapse.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-interpreted region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="914">
                    <text>a 3863-base RNA fragment that occurs in the 5-untranslated region can generate HeLa mature cell mRNA.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="915">
                    <text>a 3863-base RNA fragment that occurs in the 5-untranslated region generates HeLa mature cell mRNA within the recombinant synapses.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="916">
                    <text>a 3863-base RNA fragment that occurs in the 5-untranslated region has generated HeLa mature cell mRNA for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">a 3863-base RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">HeLa mature cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="917">
                    <text>a 3863-based RNA fragment that occurs in the 5-untranslated region can generate matur HeLa cell mRNA (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="918">
                    <text>a 3863-based RNA fragment that occurs in the 5-untranslated region can generate matur HeLa cell mRNA.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="919">
                    <text>a 3863-based RNA fragment that occurs in the 5-untranslated region generated matur HeLa cell mRNA for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="920">
                    <text>a 3863-based RNA fragment that occurs in the 5-untranslated region generated matur HeLa cell mRNA within the recombinant synapse.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="921">
                    <text>a 3863-based RNA fragment that occurs in the 5-untranslated region generates matur HeLa cell mRNA.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="922">
                    <text>a RNA fragment based on 3863 that occurs in the 5-untranslated region generated mRNA of heLa cells-G molecules of human leukocytes.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="923">
                    <text>a RNA fragment based on 3863 that occurs in the 5-untranslated region is able to generate mRNA of heLa cells .</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="924">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generated a hypersensitive chromatin I remodeling complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="925">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generated a hypersensitive chromatin I remodeling complex within the recombinant synapse.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="926">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generated a hypersensitive chromatin I remodeling complex-G molecules of human leukocytes.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="927">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates a hypersensitive DNase I within the recombinant synapses.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="928">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex generates a hypersensitive DNase I-G molecules of antigen human leukocytes.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="929">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex is able to generate a hypersensitive DNase I .</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="930">
                    <text>a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex is able to generate a hypersensitive chromatin I remodeling complex .</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive chromatin I remodeling complex</arg>
                </example>
                <example src="PERMUTATE" no="931">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF 1 reactivation complex generated A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF 1 reactivation complex</arg>
                </example>
                <example src="PERMUTATE" no="932">
                    <text>a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) generates a hypersensitive to DNase I (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="933">
                    <text>a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) can generate a hypersensitive to DNase I (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="934">
                    <text>a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) can generate a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="935">
                    <text>a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) can generate a hypersensitive to DNase I (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="936">
                    <text>a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) generated a hypersensitive to DNase I (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="937">
                    <text>a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) generated a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="938">
                    <text>a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) generates a hypersensitive to DNase I.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="939">
                    <text>a functional interaction surface (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by the N-terminal AR.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="940">
                    <text>a functional interaction surface can be generated by the N-terminal AR.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="941">
                    <text>a functional interaction surface were generated by the N-terminal RA (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="942">
                    <text>a functional interaction surface were generated by the term N-AR (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="943">
                    <text>a high-order DNA-protein complex is generated by this binding. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="944">
                    <text>a higher DNA complex (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="945">
                    <text>a higher DNA complex are generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="946">
                    <text>a higher DNA-protein complex (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="947">
                    <text>a higher DNA-protein complex (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="948">
                    <text>a higher DNA-protein complex are generated by this binding .</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="949">
                    <text>a higher DNA-protein complex is generated by this binding whose elimination removes the FHL2 link.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="950">
                    <text>a higher DNA-protein complex was generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="951">
                    <text>a higher DNA-protein complex were generated by this binding (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="952">
                    <text>a higher order DNA-protein complex (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="953">
                    <text>a higher order DNA-protein complex are generated by this binding .</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="954">
                    <text>a higher order DNA-protein complex is generated by this binding within the recombinant synapse.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="955">
                    <text>a higher order DNA-protein complex is generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="956">
                    <text>a higher-order protein&#x13;DNA complex is generated by this union. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="957">
                    <text>a higher-order protein&#x13;DNA complex was generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="958">
                    <text>a higher-order protein&#x13;DNA complex were generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="959">
                    <text>a higher-order protein DNA complex is generated by this junction within the recombinant synapse.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="960">
                    <text>a higher-order protein DNA complex will be generated by this junction.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="961">
                    <text>a higher-order protein-DNA complex (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="962">
                    <text>a higher-order protein-DNA complex is generated by this union. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="963">
                    <text>a higher-order protein-DNA complex will be generated by this union. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="964">
                    <text>a hypersensitive DNase I (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="965">
                    <text>a hypersensitive DNase I is generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex whose deletion removes the FHL2 binding.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="966">
                    <text>a hypersensitive DNase I was generated by a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex 1 coactivator-remodeling complex</arg>
                    <arg n="1">a hypersensitive DNase I</arg>
                </example>
                <example src="PERMUTATE" no="967">
                    <text>a hypersensitive to DNase I (carot, and permease from DcuB to motor, carot and aspartate) were generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1).</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="968">
                    <text>a hypersensitive to DNase I (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="969">
                    <text>a hypersensitive to DNase I (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="970">
                    <text>a hypersensitive to DNase I are generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) .</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="971">
                    <text>a hypersensitive to DNase I can be generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1).</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="972">
                    <text>a hypersensitive to DNase I is generated by a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1) within the recombinant synapses.</text>
                    <arg n="0">a SWI/SNF-related chromatin remodeling complex, EKLF re-re-re-activation complex (E-CR1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="973">
                    <text>a hypersensitive to DNase I is generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) within the recombinant synapse.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="974">
                    <text>a hypersensitive to DNase I is generated by a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1) within the recombinant synapses.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, the co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="975">
                    <text>a hypersensitive to DNase I was generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="976">
                    <text>a hypersensitive to DNase I was generated by a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1) within the recombinant synapse.</text>
                    <arg n="0">a chromatin remodeling complex related to SWI/SNF, co-activator-remodeling complex EKLF 1 (E-RC1)</arg>
                    <arg n="1">a hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="977">
                    <text>a monoclonal antibody vs. FHL2 is generated by ens within the recombinant synapse.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="978">
                    <text>a monoclonal antibody vs. FHL2 was generated by ens (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="979">
                    <text>a monoclonal antibody vs. FHL2 was generated by ens within the recombinant synapse.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="980">
                    <text>a monoclonal antibody vs. FHL2 will be generated by ens. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="981">
                    <text>a surface of functional interaction (carot, and permease from DcuB to motor, carot and aspartate) were generated by the term N-AR.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="982">
                    <text>a surface of functional interaction will be generated by the term N-AR. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="983">
                    <text>an alternative coupling of primary gene transcription can generate HLA (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="984">
                    <text>an alternative coupling of primary gene transcription generated HLA (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="985">
                    <text>an alternative coupling of primary gene transcription generates HLA within the recombinant synapse.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="986">
                    <text>an alternative coupling of primary gene transcription generates HLA-G molecules of antigen human leukocytes.</text>
                    <arg n="0">an alternative coupling of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="987">
                    <text>an alternative coupling of primary transcription of the gene generates HLA-G molecules of antigen human leukocytes.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="988">
                    <text>an alternative coupling of primary transcription of the gene has generated HLA for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="989">
                    <text>an alternative coupling of primary transcription of the gene is able to generate HLA .</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="990">
                    <text>an alternative coupling of primary transcription of the gene is able to generate HLA.</text>
                    <arg n="0">an alternative coupling of primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="991">
                    <text>an alternative coupling of the primary transcription of the gene generates HLA.</text>
                    <arg n="0">an alternative coupling of the primary transcription of the gene</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="PERMUTATE" no="992">
                    <text>biceps RNase III Dicer can generate 21-23 nt of long mature RNAs (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="993">
                    <text>biceps RNase III Dicer generated 21-23 nt of long mature RNAs for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="994">
                    <text>biceps RNase III Dicer generates 21-23 nt of long mature RNAs-G molecules of antigen human leukocytes.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="995">
                    <text>biceps RNase III Dicer has generated 21-23 nt of long mature RNAs for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">biceps RNase III Dicer</arg>
                    <arg n="1">21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="996">
                    <text>bidentate RNase III can generate mature RNA 21-23 nt (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="997">
                    <text>degradation can generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">degradation</arg>
                </example>
                <example src="PERMUTATE" no="998">
                    <text>degradation can generate specific fragments.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="999">
                    <text>degradation generates specific fragments-G molecules of antigen human leukocytes.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="1000">
                    <text>degradation has generated specific fragments for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="1001">
                    <text>does not react anaerobically with the purified Fe-S group of NRF generated spectral changes consistent with the formation of a dinitrosil-cysteine complex (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1002">
                    <text>ens can generate a monoclonal antibody vs. FHL2 (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1003">
                    <text>ens generated a monoclonal antibody vs. FHL2 (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">ens</arg>
                    <arg n="1">a monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1004">
                    <text>fumat (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by fumat B.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1005">
                    <text>fumat B can generate fumat (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1006">
                    <text>fumat B generated fumat-G molecules of human leukocytes.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1007">
                    <text>fumat B generates fumat (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1008">
                    <text>fumat B generates fumat (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1009">
                    <text>fumat is generated by fumat B within the recombinant synapses.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1010">
                    <text>fumat is generated by fumat B. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1011">
                    <text>fumat is generated by fumatase B within the recombinant synapses.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1012">
                    <text>fumat was generated by fumatase B within the recombinant synapse.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1013">
                    <text>fumat will be generated by fumat B.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1014">
                    <text>fumat will be generated by fumat B. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">fumat B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1015">
                    <text>fumatase B can generate fumat (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1016">
                    <text>fumatase B can generate fumat.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1017">
                    <text>fumatase B generated fumat for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">fumatase B</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="PERMUTATE" no="1018">
                    <text>high-order DNA protein complex (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1019">
                    <text>high-order DNA protein complex are generated by this binding (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1020">
                    <text>high-order DNA protein complex are generated by this binding .</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1021">
                    <text>high-order DNA protein complex will be generated by this binding.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1022">
                    <text>high-order protein-DNA complex (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1023">
                    <text>high-order protein-DNA complex (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by this union.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1024">
                    <text>high-order protein-DNA complex was generated by this union (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1025">
                    <text>hypersensitive to DNase I (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1).</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1026">
                    <text>hypersensitive to DNase I are generated by SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1) .</text>
                    <arg n="0">SWI/SNF chromatin remodeling complex, re-remodelation complex 1 of the EKLF (E-RC1)</arg>
                    <arg n="1">hypersensitive to DNase I</arg>
                </example>
                <example src="PERMUTATE" no="1027">
                    <text>in anaerobically reacted with the purified NR Fe-S cluster generated spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1028">
                    <text>in anaerobically reacted with the purified NR Fe-S cluster generated spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex within the recombinant synapse.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1029">
                    <text>intergenic slicing with Prnp can generate some unusual chimeric transcriptions (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1030">
                    <text>intergenic slicing with Prnp can generate some unusual chimeric transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1031">
                    <text>intergenic slicing with Prnp generated some unusual chemical transcriptions (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1032">
                    <text>intergenic slicing with Prnp generated some unusual chimeric transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1033">
                    <text>intergenic slicing with Prnp generates some unusual chimeric transcriptions-G molecules of antigen human leukocytes.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1034">
                    <text>intergenic slicing with Prnp generates some unusual symmetrical transcriptions-G molecules of antigen human leukocytes.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1035">
                    <text>intergenic slicing with Prnp is able to generate some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1036">
                    <text>intergenic slicing with Prnp is able to generate some unusual chimeric transcriptions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1037">
                    <text>intergenic spike with Prnp can generate some unusual chemical transcriptions (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1038">
                    <text>intergenic spike with Prnp can generate some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1039">
                    <text>intergenic spike with Prnp generated some unusual chemical transcriptions for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1040">
                    <text>intergenic spike with Prnp generates some unusual chemical transcriptions (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1041">
                    <text>intergenic spike with Prnp generates some unusual chemical transcriptions within the recombinant synapse.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1042">
                    <text>intergenic spike with Prnp is able to generate some unusual chemical transcriptions.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1043">
                    <text>large transcriptions of 1.7 and 2.7 kb is generated by Prnd whose elimination removes the FHL2 link.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1044">
                    <text>large transcriptions of 1.7 and 2.7 kb is generated by Prnd within the recombinant synapse.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">large transcriptions of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1045">
                    <text>long RNAs of 21-23 nt (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by Bydented RNase III dyce.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1046">
                    <text>long RNAs of 21-23 nt are generated by The biceps RNase III Dicer (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1047">
                    <text>long RNAs of 21-23 nt are generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1048">
                    <text>long RNAs of 21-23 nt is generated by Bydented RNase III dyce within the recombinant synapse.</text>
                    <arg n="0">Bydented RNase III dyce</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1049">
                    <text>long RNAs of 21-23 nt is generated by The biceps RNase III Dicer whose elimination removes the FHL2 link.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1050">
                    <text>long RNAs of 21-23 nt were generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1051">
                    <text>long mature RNAs of 21-23 nt are generated by The biceps RNase III Dicer .</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1052">
                    <text>long mature RNAs of 21-23 nt is generated by The biceps RNase III Dicer within the recombinant synapses.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1053">
                    <text>long mature RNAs of 21-23 nt will be generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">long mature RNAs of 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1054">
                    <text>mRNA of heLa cells (carot, and permease from DcuB to motor, carot and aspartate) were generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="1055">
                    <text>mRNA of heLa cells are generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="1056">
                    <text>mRNA of heLa cells is generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region whose deletion removes the FHL2 binding.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="1057">
                    <text>mRNA of heLa cells was generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region within the recombinant synapse.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="1058">
                    <text>mRNA of heLa cells was generated by a RNA fragment based on 3863 that occurs in the 5-untranslated region.</text>
                    <arg n="0">a RNA fragment based on 3863 that occurs in the 5-untranslated region</arg>
                    <arg n="1">mRNA of heLa cells</arg>
                </example>
                <example src="PERMUTATE" no="1059">
                    <text>mRNA of mature HeLa cells are generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="1060">
                    <text>mRNA of mature HeLa cells were generated by an RNA fragment of 3863 bases occurring in the 5-interpreted region.</text>
                    <arg n="0">an RNA fragment of 3863 bases occurring in the 5-interpreted region</arg>
                    <arg n="1">mRNA of mature HeLa cells</arg>
                </example>
                <example src="PERMUTATE" no="1061">
                    <text>main transcripts of 1.7 and 2.7 kb (carot, and permease from DcuB to motor, carot and aspartate) were generated by Prnd.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1062">
                    <text>main transcripts of 1.7 and 2.7 kb (carot, and permease from DcuB to motor, carot and aspartate) were generated by prnd.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1063">
                    <text>main transcripts of 1.7 and 2.7 kb are generated by PRnd .</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1064">
                    <text>main transcripts of 1.7 and 2.7 kb are generated by Prnd .</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1065">
                    <text>main transcripts of 1.7 and 2.7 kb are generated by prnd.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1066">
                    <text>main transcripts of 1.7 and 2.7 kb can be generated by prnd.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1067">
                    <text>main transcripts of 1.7 and 2.7 kb is generated by PRnd. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1068">
                    <text>main transcripts of 1.7 and 2.7 kb is generated by Prnd whose elimination removes the FHL2 link.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1069">
                    <text>main transcripts of 1.7 and 2.7 kb is generated by Prnd within the recombinant synapses.</text>
                    <arg n="0">Prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1070">
                    <text>main transcripts of 1.7 and 2.7 kb is generated by prnd within the recombinant synapse.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1071">
                    <text>main transcripts of 1.7 and 2.7 kb is generated by prnd. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1072">
                    <text>main transcripts of 1.7 and 2.7 kb was generated by PRnd (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">PRnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1073">
                    <text>matur HeLa cell mRNA are generated by a 3863-based RNA fragment that occurs in the 5-untranslated region .</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1074">
                    <text>matur HeLa cell mRNA are generated by a 3863-based RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1075">
                    <text>matur HeLa cell mRNA is generated by a 3863-based RNA fragment that occurs in the 5-untranslated region whose deletion removes the FHL2 binding.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1076">
                    <text>matur HeLa cell mRNA is generated by a 3863-based RNA fragment that occurs in the 5-untranslated region within the recombinant synapse.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1077">
                    <text>matur HeLa cell mRNA were generated by a 3863-based RNA fragment that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-based RNA fragment that occurs in the 5-untranslated region</arg>
                    <arg n="1">matur HeLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1078">
                    <text>mature RNA 21-23 nt (carot, and permease from DcuB to motor, carot and aspartate) were generated by bidentate RNase III.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1079">
                    <text>mature RNA 21-23 nt (carot, and permease from DcuB to motor, carot and aspartate) were generated by the bidentate RNase III Dicer.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1080">
                    <text>mature RNA 21-23 nt (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by bidentate RNase III.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1081">
                    <text>mature RNA 21-23 nt (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by the bidentate RNase III Dicer.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1082">
                    <text>mature RNA 21-23 nt is generated by the bidentate RNase III Dicer within the recombinant synapse.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1083">
                    <text>mature RNA 21-23 nt will be generated by bidentate RNase III. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">bidentate RNase III</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1084">
                    <text>mature heLa cell mRNA (carot, and permease from DcuB to motor, carot and aspartate) were generated by a 3863-base RNA chunk that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1085">
                    <text>mature heLa cell mRNA (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by a 3863-base RNA chunk that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1086">
                    <text>mature heLa cell mRNA were generated by a 3863-base RNA chunk that occurs in the 5-untranslated region.</text>
                    <arg n="0">a 3863-base RNA chunk that occurs in the 5-untranslated region</arg>
                    <arg n="1">mature heLa cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1087">
                    <text>mature hela cell mRNA are generated by a 3863 bases RNA chain that occurs in the non-translated region 5 .</text>
                    <arg n="0">a 3863 bases RNA chain that occurs in the non-translated region 5</arg>
                    <arg n="1">mature hela cell mRNA</arg>
                </example>
                <example src="PERMUTATE" no="1088">
                    <text>mino EE mutant acids (437 and 438) for AA generates Stat5aEE-AA DNA-binding mutant within the recombinant synapse.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1089">
                    <text>mino EE mutant acids (437 and 438) for AA generates Stat5aEE-AA DNA-binding mutant within the recombinant synapses.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1090">
                    <text>mino EE mutant acids (437 and 438) for AA has generated Stat5aEE-AA DNA-binding mutant for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1091">
                    <text>mino EE mutant acids (437 and 438) for AA is able to generate Stat5aEE-AA DNA-binding mutant .</text>
                    <arg n="0">mino EE mutant acids (437 and 438) for AA</arg>
                    <arg n="1">Stat5aEE-AA DNA-binding mutant</arg>
                </example>
                <example src="PERMUTATE" no="1092">
                    <text>mino acid mutants EE (437 and 438) in AA generated A1 (a hypersensitive complex with DNase I.</text>
                    <arg n="0">mino acid mutants EE (437 and 438) in AA</arg>
                </example>
                <example src="PERMUTATE" no="1093">
                    <text>mino acid mutants EE (437 and 438) in AA generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">mino acid mutants EE (437 and 438) in AA</arg>
                </example>
                <example src="PERMUTATE" no="1094">
                    <text>mino mutant acids EE (437 and 438) to AA can generate the DNA-binding mutant (Stat5aEE-AA) of Stat5a (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="1095">
                    <text>mino mutant acids EE (437 and 438) to AA generates the DNA-binding mutant (Stat5aEE-AA) of Stat5a (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="1096">
                    <text>mino mutant acids EE (437 and 438) to AA generates the DNA-binding mutant (Stat5aEE-AA) of Stat5a-G molecules of human leukocytes.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="1097">
                    <text>moker (carot, and permease from DcuB to motor, carot and aspartate) were generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="1098">
                    <text>moker are generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="1099">
                    <text>moker can be generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="1100">
                    <text>moker is generated by smoker B whose deletion removes the FHL2 binding.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="1101">
                    <text>moker is generated by smoker B within the recombinant synapse.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="1102">
                    <text>moker were generated by smoker B.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="1103">
                    <text>monoclonal antibody against FHL2 (carot, and permease from DcuB to motor, carot and aspartate) were generated by us.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1104">
                    <text>monoclonal antibody against FHL2 (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by nodes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1105">
                    <text>monoclonal antibody against FHL2 are generated by nodes (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1106">
                    <text>monoclonal antibody against FHL2 will be generated by us. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1107">
                    <text>monoclonal antibody vs. FHL2 is generated by nodes whose deletion removes the FHL2 binding.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1108">
                    <text>monoclonal antibody vs. FHL2 was generated by nodes (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1109">
                    <text>monoclonal antibody vs. FHL2 will be generated by nodes. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1110">
                    <text>motor will be generated by smoker B. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="1111">
                    <text>muting amino acids EE (437 and 438) to AA can generate Stat5aEE-AA.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="1112">
                    <text>muting amino acids EE (437 and 438) to AA generated Stat5aEE-AA for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="1113">
                    <text>muting amino acids EE (437 and 438) to AA generates A1 (a DNase I hypersensitivity complex.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                </example>
                <example src="PERMUTATE" no="1114">
                    <text>muting amino acids EE (437 and 438) to AA generates Stat5aEE-AA-G molecules of human leukocytes.</text>
                    <arg n="0">muting amino acids EE (437 and 438) to AA</arg>
                    <arg n="1">Stat5aEE-AA</arg>
                </example>
                <example src="PERMUTATE" no="1115">
                    <text>nNOS are able to generate superoxide .</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="1116">
                    <text>nNOS generated suspected (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="1117">
                    <text>nNOS generates suspected-G molecules of antigen human leukocytes.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="1118">
                    <text>nNOS has generated suspected for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="1119">
                    <text>no anaerobic reactions with the purified FNR Fe-S group generated spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex within the recombinant synapse.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1120">
                    <text>no anaerobic reactions with the purified FNR Fe-S group generates spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex within the recombinant synapses.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1121">
                    <text>nodes generates monoclonal antibody against FHL2 (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1122">
                    <text>nodes generates monoclonal antibody against FHL2-G molecules of human leukocytes.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1123">
                    <text>nodes generates monoclonal antibody against FHL2.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1124">
                    <text>nodes has generated monoclonal antibody against FHL2 for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1125">
                    <text>nodes has generated monoclonal antibody vs. FHL2 for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">nodes</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1126">
                    <text>none reacts anaerobically with the purified F-S group of FNR generated spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1127">
                    <text>none reacts anaerobically with the purified FNR group Fe-S generated spectral changes consistent with the formation of a dinitrosil-iron-cystein complex-G molecules of human leukocytes.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="1128">
                    <text>overlapping sequential fragments is generated by TBC method whose elimination removes the FHL2 link.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="1129">
                    <text>overlapping sequential fragments is generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="1130">
                    <text>overlapping sequential fragments was generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="1131">
                    <text>overlapping sequential fragments were generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="1132">
                    <text>peptides abeta can be generated from A0 (proteolysis of amyloid precursor proteins (APP) by beta- and gamma-secretases.</text>
                    <arg n="1">peptides abeta</arg>
                </example>
                <example src="PERMUTATE" no="1133">
                    <text>peptides abeta was generated from A0 (amyloid precursor protein proteolysis (APP) by beta- and gamma-secretases.</text>
                    <arg n="1">peptides abeta</arg>
                </example>
                <example src="PERMUTATE" no="1134">
                    <text>prnd generated main transcripts of 1.7 and 2.7 kb for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">prnd</arg>
                    <arg n="1">main transcripts of 1.7 and 2.7 kb</arg>
                </example>
                <example src="PERMUTATE" no="1135">
                    <text>proteolysis of amyloid precursor proteins (APP) can generate Abeta peptides.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1136">
                    <text>proteolysis of amyloid precursor proteins (APP) generated Abeta peptides (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1137">
                    <text>proteolysis of amyloid precursor proteins (APP) generates Abeta peptides-G molecules of antigen human leukocytes.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins (APP)</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1138">
                    <text>proteolysis of amyloid precursor proteins generates Abeta peptides (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1139">
                    <text>proteolysis of amyloid precursor proteins generates Abeta peptides (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1140">
                    <text>proteolysis of amyloid precursor proteins generates Abeta peptides within the recombinant synapse.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1141">
                    <text>proteolysis of amyloid precursor proteins generates Abeta peptides within the recombinant synapses.</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1142">
                    <text>proteolysis of amyloid precursor proteins is able to generate Abeta peptides .</text>
                    <arg n="0">proteolysis of amyloid precursor proteins</arg>
                    <arg n="1">Abeta peptides</arg>
                </example>
                <example src="PERMUTATE" no="1143">
                    <text>sequential fragment overlapping are generated by TBC method .</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="1144">
                    <text>sequential fragment overlapping is generated by TBC method within the recombinant synapses.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="1145">
                    <text>sequential fragment overlapping was generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="1146">
                    <text>sequential fragment overlapping were generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential fragment overlapping</arg>
                </example>
                <example src="PERMUTATE" no="1147">
                    <text>sequential overlapping fragments are generated by TBC method .</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="1148">
                    <text>sequential overlapping fragments are generated by TBC method.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="1149">
                    <text>sequential overlapping fragments is generated by TBC method whose deletion removes the FHL2 binding.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="1150">
                    <text>sequential overlapping fragments is generated by TBC method whose elimination removes the FHL2 link.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential overlapping fragments</arg>
                </example>
                <example src="PERMUTATE" no="1151">
                    <text>sequential superposition fragments is generated by TBC method whose elimination removes the FHL2 link.</text>
                    <arg n="0">TBC method</arg>
                    <arg n="1">sequential superposition fragments</arg>
                </example>
                <example src="PERMUTATE" no="1152">
                    <text>smoke (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by smoke B.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="1153">
                    <text>smoke B generates smoke within the recombinant synapse.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="1154">
                    <text>smoke B generates smoke-G molecules of antigen human leukocytes.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="1155">
                    <text>smoke is generated by smoke B whose elimination removes the FHL2 link.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="1156">
                    <text>smoke is generated by smoke B within the recombinant synapse.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="1157">
                    <text>smoke is generated by smoke B. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">smoke B</arg>
                    <arg n="1">smoke</arg>
                </example>
                <example src="PERMUTATE" no="1158">
                    <text>smoker B can generate motor (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="1159">
                    <text>smoker B can generate motor.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">motor</arg>
                </example>
                <example src="PERMUTATE" no="1160">
                    <text>smoker B generated moker (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="1161">
                    <text>smoker B generated moker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="1162">
                    <text>smoker B generated smoker (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="1163">
                    <text>smoker B generates moker (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="1164">
                    <text>smoker B generates moker-G molecules of antigen human leukocytes.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">moker</arg>
                </example>
                <example src="PERMUTATE" no="1165">
                    <text>smoker B generates smoker.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="1166">
                    <text>smoker B is able to generate smoker .</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="1167">
                    <text>smoker is generated by smoker B whose deletion removes the FHL2 binding.</text>
                    <arg n="0">smoker B</arg>
                    <arg n="1">smoker</arg>
                </example>
                <example src="PERMUTATE" no="1168">
                    <text>some unusual chemical transcriptions (carot, and permease from DcuB to motor, carot and aspartate) were generated by intergenic spike with Prnp.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1169">
                    <text>some unusual chemical transcriptions (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1170">
                    <text>some unusual chemical transcriptions are generated by intergenic spike with Prnp.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1171">
                    <text>some unusual chemical transcriptions is generated by intergenic slicing with Prnp within the recombinant synapse.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1172">
                    <text>some unusual chemical transcriptions was generated by intergenic spike with Prnp (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">intergenic spike with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1173">
                    <text>some unusual chemical transcriptions will be generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chemical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1174">
                    <text>some unusual chimeric transcriptions was generated by intergenic slicing with Prnp (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual chimeric transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1175">
                    <text>some unusual symmetrical transcriptions (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by intergenic slicing with Prnp.</text>
                    <arg n="0">intergenic slicing with Prnp</arg>
                    <arg n="1">some unusual symmetrical transcriptions</arg>
                </example>
                <example src="PERMUTATE" no="1176">
                    <text>specific fragments are generated by degradation .</text>
                    <arg n="0">degradation</arg>
                    <arg n="1">specific fragments</arg>
                </example>
                <example src="PERMUTATE" no="1177">
                    <text>spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex are generated by NONE reacts anaerobically with the purified FNR group FNR (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1178">
                    <text>spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex can be generated by NONE reacts anaerobically with the purified FNR group FNR.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1179">
                    <text>spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex was generated by NONE reacts anaerobically with the purified FNR group FNR within the recombinant synapse.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1180">
                    <text>spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex was generated by NONE reacts anaerobically with the purified FNR group FNR.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1181">
                    <text>spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex will be generated by NONE reacts anaerobically with the purified FNR group FNR.</text>
                    <arg n="0">NONE reacts anaerobically with the purified FNR group FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinithosyl-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1182">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex (carot, and permease from DcuB to motor, carot and aspartate) were generated by does not react anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1183">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by None reacts anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1184">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by does not react anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1185">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex was generated by None reacts anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">None reacts anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1186">
                    <text>spectral changes consistent with the formation of a dinitrosil-cysteine complex will be generated by does not react anaerobically with the purified Fe-S group of NRF.</text>
                    <arg n="0">does not react anaerobically with the purified Fe-S group of NRF</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1187">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (carot, and permease from DcuB to motor, carot and aspartate) were generated by no anaerobic reactions with the purified FNR Fe-S group.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1188">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by no anaerobic reactions with the purified FNR Fe-S group.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1189">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex are generated by no anaerobic reactions with the purified FNR Fe-S group.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1190">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex is generated by no anaerobic reactions with the purified FNR Fe-S group.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1191">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex will be generated by in anaerobically reacted with the purified NR Fe-S cluster.</text>
                    <arg n="0">in anaerobically reacted with the purified NR Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1192">
                    <text>spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex will be generated by no anaerobic reactions with the purified FNR Fe-S group. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">no anaerobic reactions with the purified FNR Fe-S group</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-ferro-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1193">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cystein complex (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by none reacts anaerobically with the purified FNR group Fe-S.</text>
                    <arg n="0">none reacts anaerobically with the purified FNR group Fe-S</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cystein complex</arg>
                </example>
                <example src="PERMUTATE" no="1194">
                    <text>spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex is generated by none reacts anaerobically with the purified F-S group of FNR. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">none reacts anaerobically with the purified F-S group of FNR</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosil-iron-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1195">
                    <text>spectral changes consistent with the formation of a dinitrosyl-cysteine complex (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by NO reacts anaerobicly with the purified NRF Fe-S cluster.</text>
                    <arg n="0">NO reacts anaerobicly with the purified NRF Fe-S cluster</arg>
                    <arg n="1">spectral changes consistent with the formation of a dinitrosyl-cysteine complex</arg>
                </example>
                <example src="PERMUTATE" no="1196">
                    <text>superoxide (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by NNOS.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="1197">
                    <text>superoxide is generated by NNOS whose deletion removes the FHL2 binding.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="1198">
                    <text>superoxide is generated by NNOS within the recombinant synapse.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="1199">
                    <text>superoxide is generated by NNOS within the recombinant synapses.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="1200">
                    <text>superoxide is generated by nNOS whose elimination removes the FHL2 link.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="1201">
                    <text>superoxide is generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="1202">
                    <text>superoxide was generated by NNOS within the recombinant synapse.</text>
                    <arg n="0">NNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="1203">
                    <text>superoxide will be generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">superoxide</arg>
                </example>
                <example src="PERMUTATE" no="1204">
                    <text>superposed sequential defects (carot, and permease from DcuB to motor, carot and aspartate) were generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="1205">
                    <text>superposed sequential defects (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="1206">
                    <text>superposed sequential defects are generated by the TBC method (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments are tested for their ability to be mounted under a matrix of PCR conditions.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="1207">
                    <text>superposed sequential defects was generated by the TBC method.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="1208">
                    <text>suspected is generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="1209">
                    <text>suspected was generated by nNOS (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="1210">
                    <text>suspected will be generated by nNOS.</text>
                    <arg n="0">nNOS</arg>
                    <arg n="1">suspected</arg>
                </example>
                <example src="PERMUTATE" no="1211">
                    <text>the 21-23 nt of long mature RNAs are generated by The biceps RNase III Dicer .</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="1212">
                    <text>the 21-23 nt of long mature RNAs was generated by The biceps RNase III Dicer (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="1213">
                    <text>the 21-23 nt of long mature RNAs were generated by The biceps RNase III Dicer (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="1214">
                    <text>the 21-23 nt of long mature RNAs will be generated by The biceps RNase III Dicer.</text>
                    <arg n="0">The biceps RNase III Dicer</arg>
                    <arg n="1">the 21-23 nt of long mature RNAs</arg>
                </example>
                <example src="PERMUTATE" no="1215">
                    <text>the DNA-binding mutant (Stat5aEE-AA) of Stat5a (of the malate, and the permease from DcuB to smoker, malate and aspartate) are generated by mino mutant acids EE (437 and 438) to AA.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="1216">
                    <text>the DNA-binding mutant (Stat5aEE-AA) of Stat5a is generated by mino mutant acids EE (437 and 438) to AA within the recombinant synapse.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="1217">
                    <text>the DNA-binding mutant (Stat5aEE-AA) of Stat5a will be generated by mino mutant acids EE (437 and 438) to AA.</text>
                    <arg n="0">mino mutant acids EE (437 and 438) to AA</arg>
                    <arg n="1">the DNA-binding mutant (Stat5aEE-AA) of Stat5a</arg>
                </example>
                <example src="PERMUTATE" no="1218">
                    <text>the N-terminal AR are able to generate a functional interaction surface .</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1219">
                    <text>the N-terminal AR generates a functional interaction surface (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1220">
                    <text>the N-terminal AR generates a functional interaction surface (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1221">
                    <text>the N-terminal AR has generated a functional interaction surface for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">the N-terminal AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1222">
                    <text>the N-terminal RA generated a functional interaction surface within the recombinant synapse.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1223">
                    <text>the N-terminal RA generated a functional interaction surface.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1224">
                    <text>the N-terminal RA generates a functional interaction surface (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1225">
                    <text>the N-terminal RA is able to generate a functional interaction surface .</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1226">
                    <text>the TBC method can generate overlapping sequential fragments (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="1227">
                    <text>the TBC method generated overlapping sequential fragments.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">overlapping sequential fragments</arg>
                </example>
                <example src="PERMUTATE" no="1228">
                    <text>the TBC method generates superposed sequential defects within the recombinant synapses.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="1229">
                    <text>the TBC method has generated superposed sequential defects for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">the TBC method</arg>
                    <arg n="1">superposed sequential defects</arg>
                </example>
                <example src="PERMUTATE" no="1230">
                    <text>the bidentate RNase III Dicer generated mature RNA 21-23 nt within the recombinant synapse.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1231">
                    <text>the bidentate RNase III Dicer generates mature RNA 21-23 nt (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">the bidentate RNase III Dicer</arg>
                    <arg n="1">mature RNA 21-23 nt</arg>
                </example>
                <example src="PERMUTATE" no="1232">
                    <text>the correct three-dimensional interaction surface (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by L723 to H3.</text>
                    <arg n="0">L723 to H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1233">
                    <text>the correct three-dimensional interaction surface can be generated from A0 (amyloid precursor protein proteolysis (APP) by beta and gamma-secretases.</text>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1234">
                    <text>the correct three-dimensional interaction surface have been generated from A0 (proteolysis of amyloid precursor proteins (APP) by beta- and gamma-secretases.</text>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1235">
                    <text>the correct three-dimensional interaction surface is generated by L723 in H3 whose elimination removes the FHL2 link.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1236">
                    <text>the correct three-dimensional interaction surface is generated by L723 in H3.</text>
                    <arg n="0">L723 in H3</arg>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1237">
                    <text>the correct three-dimensional interaction surface was generated from A0 (amyloid precursor protein proteolysis (APP) by beta- and gamma-secretases.</text>
                    <arg n="1">the correct three-dimensional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1238">
                    <text>the term N-AR generated a functional interaction surface within the recombinant synapse.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1239">
                    <text>the term N-AR generated a functional interaction surface-G molecules of human leukocytes.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="PERMUTATE" no="1240">
                    <text>the term N-AR generated a surface of functional interaction within the recombinant synapse.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="1241">
                    <text>the term N-AR generates a surface of functional interaction within the recombinant synapse.</text>
                    <arg n="0">the term N-AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="PERMUTATE" no="1242">
                    <text>this binding are able to generate high-order DNA-protein complex .</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1243">
                    <text>this binding can generate a high-order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1244">
                    <text>this binding can generate a higher DNA-protein complex (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1245">
                    <text>this binding can generate a higher order DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1246">
                    <text>this binding can generate high-order DNA-protein complex (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1247">
                    <text>this binding generated a high-order DNA-protein complex-G molecules of human leukocytes.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1248">
                    <text>this binding generated a higher DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1249">
                    <text>this binding generated a higher order DNA-protein complex (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1250">
                    <text>this binding generated high-order DNA-protein complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1251">
                    <text>this binding generates a high-order DNA-protein complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1252">
                    <text>this binding generates a high-order DNA-protein complex-G molecules of human leukocytes.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1253">
                    <text>this binding generates a higher DNA-protein complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1254">
                    <text>this binding generates high-order DNA protein complex (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1255">
                    <text>this binding has generated a high-order DNA-protein complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1256">
                    <text>this binding has generated a higher DNA-protein complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1257">
                    <text>this binding has generated a higher order DNA-protein complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1258">
                    <text>this binding has generated high-order DNA-protein complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">high-order DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1259">
                    <text>this binding is able to generate a higher DNA complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1260">
                    <text>this binding is able to generate a higher DNA-protein complex.</text>
                    <arg n="0">this binding</arg>
                    <arg n="1">a higher DNA-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1261">
                    <text>this junction generated a higher-order protein DNA complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1262">
                    <text>this junction generates a higher-order protein DNA complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1263">
                    <text>this junction generates a higher-order protein DNA complex-G molecules of antigen human leukocytes.</text>
                    <arg n="0">this junction</arg>
                    <arg n="1">a higher-order protein DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1264">
                    <text>this union are able to generate high-order protein-DNA complex .</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1265">
                    <text>this union can generate a higher-order protein&#x13;DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein&#x13;DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1266">
                    <text>this union can generate high-order protein-DNA complex (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1267">
                    <text>this union can generate high-order protein-DNA complex (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1268">
                    <text>this union generated a higher-order protein-DNA complex (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1269">
                    <text>this union generated a higher-order protein-DNA complex for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their assembly capacity under a PCR matrix.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1270">
                    <text>this union generated high-order protein-DNA complex-G molecules of human leukocytes.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">high-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1271">
                    <text>this union is able to generate a higher-order protein-DNA complex .</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1272">
                    <text>this union is able to generate a higher-order protein-DNA complex.</text>
                    <arg n="0">this union</arg>
                    <arg n="1">a higher-order protein-DNA complex</arg>
                </example>
                <example src="PERMUTATE" no="1273">
                    <text>us can generate monoclonal antibody against FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1274">
                    <text>us generated monoclonal antibody vs. FHL2 within the recombinant synapse.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1275">
                    <text>us generates monoclonal antibody vs. FHL2-G molecules of antigen human leukocytes.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody vs. FHL2</arg>
                </example>
                <example src="PERMUTATE" no="1276">
                    <text>us is able to generate monoclonal antibody against FHL2.</text>
                    <arg n="0">us</arg>
                    <arg n="1">monoclonal antibody against FHL2</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and furama will be generated by aspartate-amon lysis.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and intergenic splicing with Prnp generates some unusual symmetric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>A starting point for transcription is approximately 4 kilobases 5 in the translation codon, and sondes was generated by aspartate-amon system.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and N-terminus AR generated a surface of functional interaction.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and aspartate-amon lysase generated fumat.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>A starting point of transcription is approximately 4 kilobases 5 in the translation codon, and the N-terminal RA generated a surface of functional interaction.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and HLA will be generated by an alternative splicing of primary gene transcription.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a functional interaction surface will be generated by the N-term AR.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a surface of functional interaction was generated by N-terminus AR.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and a surface of functional interaction was generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and an alternative splicing of primary gene transcription generated HLA.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and aspartate-amon lysase generated fumat.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and furama is generated by aspartate-amonylliase.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and some unusual chemeric transcriptions will be generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>A starting point of transcription is located approximately 4 kilobases 5 to the translation codon, and some unusual symmetric transcriptions will be generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>A transcription start site is approximately 4 kilobases 5 in the translation codon, and furama has been generated by aspartate-amon lysis.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and HLA is generated by an alternative splicing of primary genetic transcription.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and fumat is generated by aspartate-ammonia lyase.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>A transcription starting point is approximately 4 kilobases 5 in the translation codon, and fumat is generated by aspartate-amon lilase.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>A1 is generated by the N-term AR (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the N-term AR</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>A1 is generated by the term N-AR (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the term N-AR</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that a surface of functional interaction has been generated by N-terminal AR.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>Although a crystal structure of RA is not available to date, it can be speculated that fumat has been generated by aspartate-amon lilase.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a functional interaction surface has been generated by the N-term AR.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="25">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a surface of functional interaction has been generated by N-terminal AR.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="26">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that a surface of functional interaction has been generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="27">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that an alternative splicing of primary genetic transcription generates HLA.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="28">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that aspartate-ammonia lyase has generated fumat.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="29">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that fumat has been generated by aspartate-ammonia lyase.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="30">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that some unusual symmetric transcriptions has been generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="31">
                    <text>Although a crystalline structure of the RA is not available to date, it can be speculated that the N-terminal RA has generated a surface of functional interaction.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="32">
                    <text>HLA (carot, and permease from DcuB to motor, carot and aspartate) were generated by an alternative splicing of primary gene transcription.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="33">
                    <text>HLA is generated by an alternative splicing of primary gene transcription whose elimination removes the FHL2 link.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="34">
                    <text>HLA is generated by an alternative splicing of primary genetic transcription whose deletion removes the FHL2 binding.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="35">
                    <text>HLA is generated by an alternative splicing of primary genetic transcription.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="36">
                    <text>HLA was generated by an alternative splicing of primary genetic transcription (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="37">
                    <text>HLA were generated by an alternative splicing of primary genetic transcription (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="38">
                    <text>HLA will be generated by an alternative splicing of primary gene transcription. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="39">
                    <text>HLA will be generated by an alternative splicing of primary genetic transcription.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="40">
                    <text>In addition, an alternative splicing of primary gene transcription, whose elimination removes the FHL2 link, generates HLA.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="41">
                    <text>In addition, an alternative splicing of primary genetic transcription, whose elimination removes the FHL2 link, generates HLA.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="42">
                    <text>In addition, aspartate-amon lilase generates fumat, as its elimination removes the FHL2 link.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="43">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of N-terminal AR, although again the relatively small fraction involved and the possibility that a surface of functional interaction is generated by not for degradation.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="44">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of N-terminal AR, though again the relatively small fraction involved and the possibility that a surface of functional interaction have not has been generated by degradation.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="45">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative splicing of primary gene transcription, but again the relatively small fraction involved and the possibility that HLA has no was generated by degradation.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="46">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative splicing of primary gene transcription, though again the relatively small fraction involved and the possibility that degradation generated no or occurred quickly excluded any definitive conclusion</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                </example>
                <example src="REPLACE" no="47">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of an alternative splicing of primary genetic transcription, although again the relatively small fraction involved and the possibility that HLA will be generated by no by degradation.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="48">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon lilase, although again the relatively small fraction involved and the possibility that fumat is generated by not for degradation.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="49">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon lysase, though again the relatively small fraction involved and the possibility that fumat are not generated by degradation.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="50">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon lysis, though again the relatively small fraction involved and the possibility that furama have not has been generated by degradation.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="51">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon system, though again the relatively small fraction involved and the possibility that sondes are not generated by degradation.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="52">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amon system, though again the relatively small fraction involved and the possibility that sondes have not has been generated by degradation.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="53">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of aspartate-amonylliase, although the relatively small fraction involved and the possibility that degradation had generated no or had occurred quickly excluded any definitive conclusion.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                </example>
                <example src="REPLACE" no="54">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic splicing with Prnp, although the relatively small fraction involved and the possibility that degradation had generated no or had occurred quickly excluded any definitive conclusion.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                </example>
                <example src="REPLACE" no="55">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic splicing with Prnp, but again the relatively small fraction involved and the possibility that some unusual symmetric transcriptions would be no generated by degradation.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="56">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic splicing with Prnp, though again the relatively small fraction involved and the possibility that some unusual chemeric transcriptions have not has been generated by degradation.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="57">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of intergenic splicing with Prnp, though again the relatively small fraction involved and the possibility that some unusual symmetric transcriptions have not has been generated by degradation.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="58">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-term AR, but again the relatively small fraction involved and the possibility that a functional interaction surface are no generated by degradation.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="59">
                    <text>In addition, there was an apparent absence of fragments of lower molecular weight as evidence of the N-terminal RA, though again the relatively small fraction involved and the possibility that a surface of functional interaction are not generated by degradation.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="60">
                    <text>In the absence of L-arginine, HLA (O(2)-) is generated by an alternative splicing of primary gene transcription.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="61">
                    <text>In the absence of L-arginine, HLA (O(2)-) was generated by an alternative splicing of primary genetic transcription.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="62">
                    <text>In the absence of L-arginine, N-terminus AR generated a surface of functional interaction (O(2)-).</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="63">
                    <text>In the absence of L-arginine, aspartate-amon lilase generated fumat (O(2)-).</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="64">
                    <text>In the absence of L-arginine, aspartate-amon lysase generates fumat (O(2)-).</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="65">
                    <text>In the absence of L-arginine, furama (O(2)-) has been generated by aspartate-amon lysis.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="66">
                    <text>In the absence of L-arginine, intergenic splicing with Prnp generates some unusual chemeric transcriptions (O(2)-).</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="67">
                    <text>In the absence of L-arginine, some unusual chemeric transcriptions (O(2)-) has been generated by intergenic splicing with Prnp.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="68">
                    <text>N-terminal AR can generate a surface of functional interaction (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="69">
                    <text>N-terminal AR generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">N-terminal AR</arg>
                </example>
                <example src="REPLACE" no="70">
                    <text>N-terminal AR generates a surface of functional interaction within the recombinant synapses.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="71">
                    <text>N-terminus AR generated a surface of functional interaction-G molecules of human leukocytes.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="72">
                    <text>N-terminus AR generated a surface of functional interaction.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="73">
                    <text>N-terminus AR generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">N-terminus AR</arg>
                </example>
                <example src="REPLACE" no="74">
                    <text>N-terminus AR generates a surface of functional interaction-G molecules of human leukocytes.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="75">
                    <text>The HLA of Stat5a has been generated by an alternative splicing of primary genetic transcription .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="76">
                    <text>The HLA of Stat5a will be generated by an alternative splicing of primary gene transcription.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="77">
                    <text>The HLA-G molecules of human leukocytes have been generated by an alternative splicing of primary gene transcription and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="78">
                    <text>The HLA-G molecules of human leukocytes were generated by an alternative splicing of primary gene transcription and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="79">
                    <text>The N-terminus AR generated the a surface of functional interaction.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="80">
                    <text>The N-terminus AR generates the a surface of functional interaction.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="81">
                    <text>The a surface of functional interaction-G molecules are generated by the N-terminal RA and show a specialized function in regulating the immune response.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="82">
                    <text>The a surface of functional interaction-G molecules of human leukocytes were generated by N-terminus AR and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="83">
                    <text>The aspartate-amon lysase generates the fumat.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="84">
                    <text>The aspartate-amon lysis generates the furama.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="85">
                    <text>The fumat of Stat5a will be generated by aspartate-ammonia lyase.The epitope of the flag will be added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="86">
                    <text>The fumat-G molecules of human leukocytes were generated by aspartate-ammonia lyase and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="87">
                    <text>The fumat-G molecules of human leukocytes were generated by aspartate-amon lysase and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="88">
                    <text>The furama of Stat5a has been generated by aspartate-amon lysis .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="89">
                    <text>The furama-G molecules are generated by aspartate-amon lysis and show a specialized function in regulating the immune response.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="90">
                    <text>The furama-G molecules of human leukocytes have been generated by aspartate-amon lysis and have shown a specialized function in regulating the immune response.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="91">
                    <text>The furama-G molecules of human leukocytes were generated by aspartate-amon lysis and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="92">
                    <text>The furama-G molecules of human leukocytes were generated by aspartate-amon lysis and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="93">
                    <text>The intergenic splicing with Prnp generated the some unusual chemeric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="94">
                    <text>The intergenic splicing with Prnp generated the some unusual symmetric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="95">
                    <text>The some unusual chemeric transcriptions of Stat5a has been generated by intergenic splicing with Prnp .The epitope of FLAAG has been added to the C terminal of Stat5aEE-AA.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="96">
                    <text>The some unusual symmetric transcriptions-G molecules of human leukocytes were generated by intergenic splicing with Prnp and have demonstrated a specialized function in the regulation of the immune response.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="97">
                    <text>The some unusual symmetric transcriptions-G molecules of human leukocytes were generated by intergenic splicing with Prnp and showed a specialized function in regulating the immune response.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="98">
                    <text>These are HLA reductase (coded by the operon of frdABCD), an alternative splicing of primary gene transcription, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="99">
                    <text>These are HLA reductase (encoded by the operon frdABCD), an alternative splicing of primary genetic transcription, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="100">
                    <text>These are a functional interaction surface reductase (encoded by the operon frdABCD), the N-term AR, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="101">
                    <text>These are a functional interaction surface reductase (encoded by the operon frdABCD), the N-term AR, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="102">
                    <text>These are a surface of functional interaction reductase (coded by the operon of frdABCD), N-terminal AR, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="103">
                    <text>These are a surface of functional interaction reductase (encoded by the operon frdABCD), N-terminus AR, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="104">
                    <text>These are a surface of functional interaction reductase (encoded by the operon frdABCD), the N-terminal RA, which generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="105">
                    <text>These are a surface of functional interaction reductase (encoded by the operon frdABCD), the N-terminal RA, which have generated fumat from malate, the permease DcuB for A1 (fumat ), malate, and aspartate.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="106">
                    <text>These are fumat reductase (coded by the operon of frdABCD), aspartate-ammonia lyase, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="107">
                    <text>These are fumat reductase (coded by the operon of frdABCD), aspartate-amon lysase, which will generate smoke of malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="108">
                    <text>These are fumat reductase (encoded by the operon frdABCD), aspartate-amon lysase, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="109">
                    <text>These are some unusual chemeric transcriptions reductase (encoded by the operon frdABCD), intergenic splicing with Prnp, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="110">
                    <text>These are some unusual symmetric transcriptions reductase (encoded by the operon frdABCD), intergenic splicing with Prnp, which will generate fumat from malate, the permease DcuB for fumat, malate and aspartate.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="111">
                    <text>These are sondes reductase (coded by the operon of frdABCD), aspartate-amon system, which generated smoke malt, DcuB permeate to smoke, malt and aspartate.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="112">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, a functional interaction surface is generated by the N-term AR.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="113">
                    <text>To specifically analyse the protein expression of FHL2 in human tissue, furama is generated by aspartate-amonylliase.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="114">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, N-terminal AR generates a surface of functional interaction.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="115">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, N-terminal AR will generate a surface of functional interaction.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="116">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, a surface of functional interaction is generated by N-terminal AR.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="117">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, an alternative splicing of primary gene transcription generates HLA.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="118">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, aspartate-amon system generates sondes.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="119">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, aspartate-amon system will generate sondes.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="120">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, sondes is generated by aspartate-amon system.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="121">
                    <text>To specifically analyse the protein expression of FHL2 in human tissues, the N-terminal RA generates a surface of functional interaction.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="122">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, fumat was generated by aspartate-ammonia lyase.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="123">
                    <text>To specifically analyze the protein expression of FHL2 in human tissue, fumat was generated by aspartate-amon lilase.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="124">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues aspartate-ammonia lyase can generate fumat.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="125">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues aspartate-amon system can generate sondes.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="126">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues aspartate-amonylliase can generate furama.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="127">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, N-terminus AR will generate a surface of functional interaction.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="128">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, aspartate-amon lilase may generate fumat.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="129">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, aspartate-amon lilase will generate fumat.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="130">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, aspartate-amon lysis generates furama .</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="131">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, aspartate-amon system may generate sondes.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="132">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, aspartate-amon system will generate sondes.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="133">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, fumat was generated by aspartate-amon lilase.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="134">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, furama was generated by aspartate-amon lysis.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="135">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, intergenic splicing with Prnp generates some unusual chemeric transcriptions .</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="136">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, intergenic splicing with Prnp will generate some unusual chemeric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="137">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, intergenic splicing with Prnp will generate some unusual symmetric transcriptions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="138">
                    <text>To specifically analyze the protein expression of FHL2 in human tissues, the N-term AR generates a functional interaction surface .</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="139">
                    <text>We believe that N-terminal AR is able to generate a surface of functional interaction within the recombinant synapse.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="140">
                    <text>We believe that aspartate-amon lilase is able to generate fumat within the reombian synapses.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="141">
                    <text>We believe that aspartate-amon lysase is able to generate fumat within the recombinant synapse.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="142">
                    <text>We believe that aspartate-amon lysis is able to generate furama within the reombian synapses.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="143">
                    <text>We believe that aspartate-amon system is able to generate sondes within the recombinant synapse.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="144">
                    <text>We believe that intergenic splicing with Prnp is able to generate some unusual chemeric transcriptions within the recombinant synapse.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="145">
                    <text>We believe that the N-term AR is shown to generate a functional interaction surface within the reombine synapses.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="146">
                    <text>a functional interaction surface (carot, and permease from DcuB to motor, carot and aspartate) were generated by the N-term AR.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="147">
                    <text>a functional interaction surface (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by the N-term AR.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="148">
                    <text>a functional interaction surface is generated by the N-term AR whose deletion removes the FHL2 binding.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="149">
                    <text>a functional interaction surface is generated by the N-term AR whose elimination removes the FHL2 link.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="150">
                    <text>a functional interaction surface is generated by the N-term AR.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="151">
                    <text>a functional interaction surface was generated by the N-term AR (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="152">
                    <text>a surface of functional interaction (carot, and permease from DcuB to motor, carot and aspartate) were generated by N-terminus AR.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="153">
                    <text>a surface of functional interaction (carote, and the permease from DcuB to smoker, carote and aspartate) were generated by the N-terminal RA.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="154">
                    <text>a surface of functional interaction are generated by N-terminal AR.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="155">
                    <text>a surface of functional interaction is generated by N-terminal AR whose deletion removes the FHL2 binding.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="156">
                    <text>a surface of functional interaction is generated by N-terminal AR whose elimination removes the FHL2 link.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="157">
                    <text>a surface of functional interaction is generated by N-terminal AR within the recombinant synapse.</text>
                    <arg n="0">N-terminal AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="158">
                    <text>a surface of functional interaction is generated by N-terminus AR within the recombinant synapse.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="159">
                    <text>a surface of functional interaction is generated by N-terminus AR. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">N-terminus AR</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="160">
                    <text>a surface of functional interaction was generated by the N-terminal RA (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="161">
                    <text>an alternative splicing of primary gene transcription can generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                </example>
                <example src="REPLACE" no="162">
                    <text>an alternative splicing of primary gene transcription can generate HLA (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="163">
                    <text>an alternative splicing of primary gene transcription generated HLA (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="164">
                    <text>an alternative splicing of primary gene transcription generates HLA-G molecules of human leukocytes.</text>
                    <arg n="0">an alternative splicing of primary gene transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="165">
                    <text>an alternative splicing of primary genetic transcription can generate HLA (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="166">
                    <text>an alternative splicing of primary genetic transcription generated A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                </example>
                <example src="REPLACE" no="167">
                    <text>an alternative splicing of primary genetic transcription generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a. The FLA epitope was added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                </example>
                <example src="REPLACE" no="168">
                    <text>an alternative splicing of primary genetic transcription generates HLA.</text>
                    <arg n="0">an alternative splicing of primary genetic transcription</arg>
                    <arg n="1">HLA</arg>
                </example>
                <example src="REPLACE" no="169">
                    <text>aspartate-ammonia lyase can generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                </example>
                <example src="REPLACE" no="170">
                    <text>aspartate-ammonia lyase generated fumat (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="171">
                    <text>aspartate-ammonia lyase generated fumat (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="172">
                    <text>aspartate-ammonia lyase generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                </example>
                <example src="REPLACE" no="173">
                    <text>aspartate-ammonia lyase has generated fumat for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="174">
                    <text>aspartate-amon lilase are able to generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                </example>
                <example src="REPLACE" no="175">
                    <text>aspartate-amon lilase can generate fumat (approximately 0.4 to 0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposition fragments can be tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="176">
                    <text>aspartate-amon lilase can generate fumat (approximately 0.4-0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of overlapping fragments can be tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="177">
                    <text>aspartate-amon lilase generated A1 (a hypersensitive complex with DNase I.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                </example>
                <example src="REPLACE" no="178">
                    <text>aspartate-amon lilase generates fumat (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="179">
                    <text>aspartate-amon lilase generates fumat within the recombinant synapse.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="180">
                    <text>aspartate-amon lilase generates fumat-G molecules of human leukocytes.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="181">
                    <text>aspartate-amon lilase is able to generate fumat .</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="182">
                    <text>aspartate-amon lysase generates A1 (a DNase I hypersensitivity complex.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                </example>
                <example src="REPLACE" no="183">
                    <text>aspartate-amon lysis are able to generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                </example>
                <example src="REPLACE" no="184">
                    <text>aspartate-amon lysis generates furama (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="185">
                    <text>aspartate-amon lysis generates furama within the recombinant synapse.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="186">
                    <text>aspartate-amon system are able to generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">aspartate-amon system</arg>
                </example>
                <example src="REPLACE" no="187">
                    <text>aspartate-amon system generated A1 (a hypersensitive complex with DNase I.</text>
                    <arg n="0">aspartate-amon system</arg>
                </example>
                <example src="REPLACE" no="188">
                    <text>aspartate-amon system generated A1 (the DNA-binding mutant (Stat5aEE-AA) from Stat5a.</text>
                    <arg n="0">aspartate-amon system</arg>
                </example>
                <example src="REPLACE" no="189">
                    <text>aspartate-amon system generated sondes (approximately 0.4.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be mounted under a PCR condition matrix.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="190">
                    <text>aspartate-amon system generates sondes (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="191">
                    <text>aspartate-amon system generates sondes.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="192">
                    <text>aspartate-amonylliase are able to generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                </example>
                <example src="REPLACE" no="193">
                    <text>aspartate-amonylliase generated furama.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="194">
                    <text>fumat (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by aspartate-ammonia lyase.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="195">
                    <text>fumat (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by aspartate-amon lysase.</text>
                    <arg n="0">aspartate-amon lysase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="196">
                    <text>fumat are generated by aspartate-ammonia lyase.</text>
                    <arg n="0">aspartate-ammonia lyase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="197">
                    <text>fumat was generated by aspartate-amon lilase (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="198">
                    <text>fumat was generated by aspartate-amon lilase.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="199">
                    <text>fumat were generated by aspartate-amon lilase (approximately 0.4&#x13;0.5 kb) for each genetic sequence, and simultaneous and sequential combinations of superposed fragments were tested for their ability to be assembled under a PCR matrix of conditions.</text>
                    <arg n="0">aspartate-amon lilase</arg>
                    <arg n="1">fumat</arg>
                </example>
                <example src="REPLACE" no="200">
                    <text>furama (from malate, and permease from DcuB to A1 (smoker), malate and aspartate) are generated by aspartate-amon lysis.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="201">
                    <text>furama were generated by aspartate-amonylliase.</text>
                    <arg n="0">aspartate-amonylliase</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="202">
                    <text>furama will be generated by aspartate-amon lysis.</text>
                    <arg n="0">aspartate-amon lysis</arg>
                    <arg n="1">furama</arg>
                </example>
                <example src="REPLACE" no="203">
                    <text>intergenic splicing with Prnp are able to generate A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                </example>
                <example src="REPLACE" no="204">
                    <text>intergenic splicing with Prnp can generate A1 (The DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                </example>
                <example src="REPLACE" no="205">
                    <text>intergenic splicing with Prnp generated A1 (a hypersensitive complex with DNase I.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                </example>
                <example src="REPLACE" no="206">
                    <text>intergenic splicing with Prnp generates A1 (the DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                </example>
                <example src="REPLACE" no="207">
                    <text>intergenic splicing with Prnp generates some unusual chemeric transcriptions (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="208">
                    <text>intergenic splicing with Prnp has generated some unusual symmetric transcriptions for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="209">
                    <text>some unusual chemeric transcriptions was generated by intergenic splicing with Prnp within the recombinant synapse.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="210">
                    <text>some unusual chemeric transcriptions will be generated by intergenic splicing with Prnp. The FLA epitope will be added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual chemeric transcriptions</arg>
                </example>
                <example src="REPLACE" no="211">
                    <text>some unusual symmetric transcriptions is generated by intergenic splicing with Prnp. The FLA epitope is added to the C-therminus of Stat5aEE-AA.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="212">
                    <text>some unusual symmetric transcriptions was generated by intergenic splicing with Prnp within the recombinant synapse.</text>
                    <arg n="0">intergenic splicing with Prnp</arg>
                    <arg n="1">some unusual symmetric transcriptions</arg>
                </example>
                <example src="REPLACE" no="213">
                    <text>sondes can be generated by aspartate-amon system.</text>
                    <arg n="0">aspartate-amon system</arg>
                    <arg n="1">sondes</arg>
                </example>
                <example src="REPLACE" no="214">
                    <text>the N-term AR are able to generate a functional interaction surface .</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="215">
                    <text>the N-term AR can generate A1 (The DNA-binding mutant (Stat5aEE-AA) of Stat5a.</text>
                    <arg n="0">the N-term AR</arg>
                </example>
                <example src="REPLACE" no="216">
                    <text>the N-term AR generates a functional interaction surface (approximately 0.4-0.5 kb) for each of the genetic sequences, and simultaneous and sequential combinations of overlapping fragments are tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="217">
                    <text>the N-term AR has generated a functional interaction surface for each genetic sequence, and simultaneous and sequential combinations of superposed fragments have been tested for their ability to be mounted under a PCR matrix of conditions.</text>
                    <arg n="0">the N-term AR</arg>
                    <arg n="1">a functional interaction surface</arg>
                </example>
                <example src="REPLACE" no="218">
                    <text>the N-terminal RA can generate a surface of functional interaction.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="219">
                    <text>the N-terminal RA generated a surface of functional interaction (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments were tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="220">
                    <text>the N-terminal RA generated a surface of functional interaction within the recombinant synapse.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="221">
                    <text>the N-terminal RA generates a surface of functional interaction (approximately 0.4 to 0.5 kb) for each gene sequence, and simultaneous and sequential combinations of overlapping fragments are tested for their assembly capacity in a variety of PCR conditions.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
                <example src="REPLACE" no="222">
                    <text>the N-terminal RA generates a surface of functional interaction-G molecules of antigen human leukocytes.</text>
                    <arg n="0">the N-terminal RA</arg>
                    <arg n="1">a surface of functional interaction</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
